Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
neutrophil degranulation (GO:0043312),27/481,2.5350111550301593e-25,1.3375747458883352e-22,0,0,25.175780501819574,1425.8159605856888,FCN1;GRN;DDX3X;ITGB2;SLC2A3;PYGL;PSAP;S100A12;B2M;CAP1;MGAM;HLA-B;HLA-C;CYBB;PPBP;MMP8;OLFM4;LYZ;MMP9;PKM;LCN2;BPI;CEACAM8;YPEL5;S100A9;S100A8;LTF
neutrophil activation involved in immune response (GO:0002283),27/485,3.1612914652665934e-25,1.3375747458883352e-22,0,0,24.950778431744826,1407.5643990690617,FCN1;GRN;DDX3X;ITGB2;SLC2A3;PYGL;PSAP;S100A12;B2M;CAP1;MGAM;HLA-B;HLA-C;CYBB;PPBP;MMP8;OLFM4;LYZ;MMP9;PKM;LCN2;BPI;CEACAM8;YPEL5;S100A9;S100A8;LTF
neutrophil mediated immunity (GO:0002446),27/488,3.7258349467641652e-25,1.3375747458883352e-22,0,0,24.784589267188533,1394.1166980202568,FCN1;GRN;DDX3X;ITGB2;SLC2A3;PYGL;PSAP;S100A12;B2M;CAP1;MGAM;HLA-B;HLA-C;CYBB;PPBP;MMP8;OLFM4;LYZ;MMP9;PKM;LCN2;BPI;CEACAM8;YPEL5;S100A9;S100A8;LTF
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",5/8,3.128219537744567e-11,8.422731105377245e-9,0,0,488.3333333333333,11811.793002129836,HLA-B;HLA-C;HLA-A;B2M;HLA-E
cytokine-mediated signaling pathway (GO:0019221),17/621,6.544746356937894e-11,1.4097383652844224e-8,0,0,9.71177270577105,227.7388690493479,CSF3R;ITGB2;HLA-B;F13A1;HLA-C;HLA-A;PPBP;MMP9;HIF1A;HLA-E;NFKBIA;HNRNPDL;LCN2;HLA-DRA;LCP1;B2M;MCL1
defense response to bacterium (GO:0042742),10/176,8.293253866483506e-10,1.4886390690337893e-7,0,0,18.895582329317268,395.1143459711646,LCN2;S100A12;DEFA3;BPI;HLA-A;LYZ;S100A9;S100A8;HLA-E;LTF
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),4/7,5.667792163063058e-9,7.630265199523641e-7,0,0,385.0048309178744,7310.651212664233,HLA-B;HLA-C;HLA-A;HLA-E
"antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",4/7,5.667792163063058e-9,7.630265199523641e-7,0,0,385.0048309178744,7310.651212664233,HLA-B;HLA-C;HLA-A;HLA-E
innate immune response (GO:0045087),11/302,1.2021136512147307e-8,1.4385293359536279e-6,0,0,11.971843476333001,218.32571308509603,FCN1;CD74;DDX3X;LCN2;CYBB;S100A12;DEFA3;BPI;B2M;HLA-E;LTF
platelet degranulation (GO:0002576),8/125,1.7767662364850286e-8,1.836677922292117e-6,0,0,20.838921761998684,371.88901697957004,SRGN;APLP2;PLEK;PSAP;F13A1;FLNA;PPBP;TLN1
regulated exocytosis (GO:0045055),9/180,1.8759013133902774e-8,1.836677922292117e-6,0,0,16.24671052631579,289.05483689572486,SRGN;APLP2;PLEK;PSAP;F13A1;MYH9;FLNA;PPBP;TLN1
positive regulation of inflammatory response (GO:0050729),7/89,3.490273326935258e-8,3.1325203109243944e-6,0,0,25.667960088691796,440.736860098999,NFKBIA;GRN;NFKBIZ;S100A12;MMP8;S100A9;S100A8
regulation of inflammatory response (GO:0050727),9/206,6.014476927734045e-8,4.982762808591973e-6,0,0,14.08391497461929,234.1663723133566,NFKBIA;GRN;NFKBIZ;TNFAIP3;S100A12;MMP8;MMP9;S100A9;S100A8
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),5/33,1.235222540759032e-7,9.502390545696268e-6,0,0,52.25577731092437,831.2245240246335,HLA-B;HLA-C;HLA-A;B2M;HLA-E
antigen processing and presentation of endogenous peptide antigen (GO:0002483),4/14,1.5900236281366371e-7,1.1416369650021054e-5,0,0,115.4608695652174,1807.4644910445975,HLA-DRA;HLA-A;B2M;HLA-E
interferon-gamma-mediated signaling pathway (GO:0060333),6/68,1.7550224161282117e-7,1.1813494638563024e-5,0,0,28.692826191622533,446.3345294199804,HLA-B;HLA-C;HLA-DRA;HLA-A;B2M;HLA-E
positive regulation of T cell mediated immunity (GO:0002711),5/36,1.9454639277076067e-7,1.2325086177300543e-5,0,0,47.191650853889946,729.23347647798,HLA-B;HLA-DRA;HLA-A;B2M;HLA-E
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",6/73,2.690633500826404e-7,1.6098957113277984e-5,0,0,26.544887502784583,401.5795255074512,HLA-B;CYBB;HLA-C;HLA-A;B2M;HLA-E
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),6/78,4.0018753712191446e-7,2.2684314604226413e-5,0,0,24.695273631840795,363.79428845444085,HLA-B;HLA-C;CYBB;HLA-A;B2M;HLA-E
protection from natural killer cell mediated cytotoxicity (GO:0042270),3/6,9.256656572793935e-7,4.984709564449534e-5,0,0,284.62857142857143,3954.274362395039,HLA-B;HLA-A;HLA-E
regulation of intrinsic apoptotic signaling pathway (GO:2001242),5/52,1.2817725831412477e-6,6.5736622478244e-5,0,0,31.101376720901126,421.96066983111683,DDX3X;MMP9;S100A9;S100A8;MCL1
positive regulation of defense response (GO:0031349),6/98,1.5485043853594683e-6,7.580632831964306e-5,0,0,19.30726800778715,258.2968984212206,NFKBIA;GRN;NFKBIZ;S100A12;S100A9;S100A8
defense response to fungus (GO:0050832),4/24,1.6419526045731566e-6,7.688621544023e-5,0,0,57.70144927536232,768.5616323643894,S100A12;S100A9;S100A8;LTF
positive regulation of T cell mediated cytotoxicity (GO:0001916),4/26,2.297398734148444e-6,1.0309576819491142e-4,0,0,52.45059288537549,681.0044968744282,HLA-B;HLA-DRA;HLA-A;HLA-E
"regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",3/8,2.578312212339619e-6,1.1107369010759078e-4,0,0,170.76,2197.403809663263,HLA-A;VSIR;HLA-E
regulation of T cell mediated cytotoxicity (GO:0001914),4/29,3.6197951655044545e-6,1.4498441104061183e-4,0,0,46.149565217391306,578.2121999566331,HLA-B;HLA-DRA;HLA-A;HLA-E
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),5/64,3.6347066834693777e-6,1.4498441104061183e-4,0,0,24.76071784646062,310.1275488633939,S100A12;DEFA3;PPBP;S100A9;LTF
regulation of immune response (GO:0050776),7/179,4.05135021512268e-6,1.5583229220311168e-4,0,0,12.181553911205073,151.25178109061147,ITGB2;HLA-B;HLA-C;HLA-DRA;HLA-A;B2M;HLA-E
cellular response to interferon-gamma (GO:0071346),6/121,5.292704685023094e-6,1.9656010157827146e-4,0,0,15.427903958468526,187.43640011269716,HLA-B;HLA-C;HLA-DRA;HLA-A;B2M;HLA-E
neutrophil chemotaxis (GO:0030593),5/70,5.672520390571652e-6,2.0364348202152232e-4,0,0,22.468325791855204,271.41461253814447,ITGB2;S100A12;PPBP;S100A9;S100A8
regulation of tumor necrosis factor production (GO:0032680),6/124,6.096767762429173e-6,2.0759335448342027e-4,0,0,15.033392360232735,180.51724420721524,TNFAIP3;BPI;MMP8;VSIR;HLA-E;LTF
positive regulation of cytokine production involved in immune response (GO:0002720),4/33,6.168047672673583e-6,2.0759335448342027e-4,0,0,39.77611194402799,477.15933788776255,LAPTM5;HLA-A;B2M;HLA-E
granulocyte chemotaxis (GO:0071621),5/73,6.9803199117695775e-6,2.2781225893866164e-4,0,0,21.473832179930795,254.94626466589082,ITGB2;S100A12;PPBP;S100A9;S100A8
platelet aggregation (GO:0070527),4/36,8.805873341129527e-6,2.789389878940147e-4,0,0,36.041666666666664,419.5283026413933,PLEK;FLNA;MYH9;TLN1
neutrophil migration (GO:1990266),5/77,9.078614387832075e-6,2.793619341627184e-4,0,0,20.276756535947712,235.4048091782717,ITGB2;S100A12;PPBP;S100A9;S100A8
negative regulation of apoptotic process (GO:0043066),10/485,1.0142458040851228e-5,3.0342853638879927e-4,0,0,6.500250626566416,74.74495306223807,NFKBIA;CD74;SFPQ;GRN;DDX3X;RNF213;FLNA;MMP9;LTF;MCL1
positive regulation of response to external stimulus (GO:0032103),6/139,1.1743586953049814e-5,3.418335986063419e-4,0,0,13.327797104702054,151.29986170865928,NFKBIA;GRN;NFKBIZ;S100A12;S100A9;S100A8
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),4/43,1.809640208329246e-5,5.128901327291047e-4,0,0,29.562244518766256,322.81372140711716,HLA-B;HLA-DRA;HLA-A;HLA-E
antibacterial humoral response (GO:0019731),4/44,1.985127092452091e-5,5.344954696427255e-4,0,0,28.821739130434782,312.05995959947745,DEFA3;HLA-A;HLA-E;LTF
homotypic cell-cell adhesion (GO:0034109),4/44,1.985127092452091e-5,5.344954696427255e-4,0,0,28.821739130434782,312.05995959947745,PLEK;FLNA;MYH9;TLN1
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),3/16,2.5247795920511977e-5,6.632164928388147e-4,0,0,65.65054945054945,695.0273787715687,HLA-B;HLA-A;HLA-E
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),4/48,2.8142187880940795e-5,7.216461035184104e-4,0,0,26.19631093544137,274.49125299082726,TNFAIP3;BPI;VSIR;LTF
positive regulation of alpha-beta T cell activation (GO:0046635),3/20,5.0861068971298995e-5,0.0012539363371557022,0,0,50.19327731092437,496.2314582905286,HLA-DRA;HLA-A;HLA-E
regulation of interleukin-6 production (GO:0032675),5/110,5.122859687544187e-5,0.0012539363371557022,0,0,13.880952380952381,137.13288034369114,CD74;HLA-B;TNFAIP3;BPI;MMP8
negative regulation of cytokine production (GO:0001818),6/182,5.369460664536207e-5,0.0012850909190456655,0,0,10.049694708276798,98.81058817517932,SRGN;LAPTM5;TNFAIP3;BPI;MMP8;VSIR
negative regulation of programmed cell death (GO:0043069),8/381,7.357501915701259e-5,0.0017226151224370124,0,0,6.452134460713549,61.40628637256956,NFKBIA;CD74;DDX3X;LAPTM5;FLNA;MMP9;LTF;MCL1
amyloid fibril formation (GO:1990000),4/63,8.266614716890316e-5,0.0018942859681044407,0,0,19.521493490542863,183.51571136713417,LYZ;B2M;ITM2B;LTF
cellular response to type I interferon (GO:0071357),4/65,9.344374301460607e-5,0.0020538553311577703,0,0,18.879543834640057,175.16725816415473,HLA-B;HLA-C;HLA-A;HLA-E
type I interferon signaling pathway (GO:0060337),4/65,9.344374301460607e-5,0.0020538553311577703,0,0,18.879543834640057,175.16725816415473,HLA-B;HLA-C;HLA-A;HLA-E
negative regulation of cell development (GO:0010721),3/26,1.1418925071263456e-4,0.0024596364603501485,0,0,37.088198757763976,336.6738132577794,RFLNB;B2M;LTF
defense response to Gram-positive bacterium (GO:0050830),4/70,1.2481960171863352e-4,0.0026358962951170254,0,0,17.444883618796663,156.80579699633762,DEFA3;HLA-A;LYZ;HLA-E
peptidyl-cysteine S-nitrosylation (GO:0018119),2/5,1.3047092716623584e-4,0.0027022536261160765,0,0,187.07981220657277,1673.3092146174563,S100A9;S100A8
defense response to Gram-negative bacterium (GO:0050829),4/73,1.4695391453459396e-4,0.0029862144519576922,0,0,16.683889939088427,147.24186090426966,DEFA3;BPI;LYZ;LTF
positive regulation of intracellular signal transduction (GO:1902533),9/546,1.619097787663583e-4,0.003195824137593492,0,0,5.077688547486034,44.320458752325024,CD74;DDX3X;LAPTM5;FLNA;S100A12;MMP8;S100A9;S100A8;LTF
positive regulation of immune response (GO:0050778),4/75,1.6320364676661287e-4,0.003195824137593492,0,0,16.21228822208614,141.37945026420255,CD74;GRN;ITGB2;HLA-DRA
regulation of macrophage activation (GO:0043030),3/30,1.7645259689293347e-4,0.0033935615509587385,0,0,31.58730158730159,272.99193647793965,CD74;BPI;MMP8
inflammatory response (GO:0006954),6/230,1.9398460550525668e-4,0.0036254824157870005,0,0,7.876998933901919,67.33047392232244,ITGB2;CYBB;PPBP;LYZ;S100A9;S100A8
positive regulation of receptor binding (GO:1900122),2/6,1.952441783803584e-4,0.0036254824157870005,0,0,140.30281690140845,1198.3627797911195,B2M;MMP9
regulation of NIK/NF-kappaB signaling (GO:1901222),4/80,2.094670961523966e-4,0.0038236620772225615,0,0,15.141876430205949,128.26598562770397,NFKBIA;DDX3X;LAPTM5;MMP8
endodermal cell differentiation (GO:0035987),3/32,2.1444188498565513e-4,0.003849231835492509,0,0,29.40591133004926,248.40560638374683,ITGB2;MMP8;MMP9
positive regulation of cytokine production (GO:0001819),7/335,2.1949930894443309e-4,0.003875422225133679,0,0,6.337444567627495,53.38765636876646,FCN1;CD74;LAPTM5;HLA-A;MMP8;HIF1A;HLA-E
actin filament organization (GO:0007015),5/152,2.3520852296358432e-4,0.004085799665028715,0,0,9.893957583033213,82.66439262050531,TPM3;RFLNB;FAT1;FLNA;LCP1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),5/155,2.5750392339534214e-4,0.004319027552863202,0,0,9.694607843137256,80.12084998561943,NFKBIA;S100A12;S100A9;S100A8;LTF
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),2/7,2.726962614621149e-4,0.004319027552863202,0,0,112.23661971830985,921.142995474641,HIF1A;MCL1
glutamine transport (GO:0006868),2/7,2.726962614621149e-4,0.004319027552863202,0,0,112.23661971830985,921.142995474641,SLC38A1;SLC38A2
iron coordination entity transport (GO:1901678),2/7,2.726962614621149e-4,0.004319027552863202,0,0,112.23661971830985,921.142995474641,LCN2;LTF
modulation by symbiont of host apoptotic process (GO:0052150),2/7,2.726962614621149e-4,0.004319027552863202,0,0,112.23661971830985,921.142995474641,SFPQ;RNF213
protein localization to cytoplasmic stress granule (GO:1903608),2/7,2.726962614621149e-4,0.004319027552863202,0,0,112.23661971830985,921.142995474641,DDX3X;YBX1
response to lipopolysaccharide (GO:0032496),5/159,2.896890125758184e-4,0.004521667631074731,0,0,9.44088999236058,76.91212286593115,TNFAIP3;DEFA3;PPBP;S100A9;S100A8
endoderm formation (GO:0001706),3/36,3.0547785732446545e-4,0.004569439615811796,0,0,25.836363636363636,209.11005209887384,ITGB2;MMP8;MMP9
positive regulation of cytokine-mediated signaling pathway (GO:0001961),3/36,3.0547785732446545e-4,0.004569439615811796,0,0,25.836363636363636,209.11005209887384,CD74;LAPTM5;HIF1A
retina homeostasis (GO:0001895),3/36,3.0547785732446545e-4,0.004569439615811796,0,0,25.836363636363636,209.11005209887384,LYZ;B2M;LTF
alpha-beta T cell activation (GO:0046631),2/8,3.6273631743584525e-4,0.005051891204364232,0,0,93.52582159624413,740.8960694909396,HLA-A;HLA-E
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),2/8,3.6273631743584525e-4,0.005051891204364232,0,0,93.52582159624413,740.8960694909396,HLA-A;B2M
leukocyte aggregation (GO:0070486),2/8,3.6273631743584525e-4,0.005051891204364232,0,0,93.52582159624413,740.8960694909396,S100A9;S100A8
negative regulation by symbiont of host apoptotic process (GO:0033668),2/8,3.6273631743584525e-4,0.005051891204364232,0,0,93.52582159624413,740.8960694909396,SFPQ;RNF213
negative regulation by symbiont of host programmed cell death (GO:0052041),2/8,3.6273631743584525e-4,0.005051891204364232,0,0,93.52582159624413,740.8960694909396,SFPQ;RNF213
cellular response to cytokine stimulus (GO:0071345),8/482,3.658751290068803e-4,0.005051891204364232,0,0,5.051087309315157,39.970357340932765,CSF3R;ITGB2;LCN2;F13A1;MMP9;HIF1A;RBMX;MCL1
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),3/40,4.183063282338499e-4,0.0057027331076943836,0,0,23.038610038610038,179.2241796171757,SFPQ;S100A9;S100A8
"regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",2/9,4.6527396164461245e-4,0.006037350080617441,0,0,80.16096579476861,615.0658047802893,HLA-A;HLA-E
peptidyl-cysteine modification (GO:0018198),2/9,4.6527396164461245e-4,0.006037350080617441,0,0,80.16096579476861,615.0658047802893,S100A9;S100A8
"positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",2/9,4.6527396164461245e-4,0.006037350080617441,0,0,80.16096579476861,615.0658047802893,HLA-A;HLA-E
positive regulation of macrophage cytokine production (GO:0060907),2/9,4.6527396164461245e-4,0.006037350080617441,0,0,80.16096579476861,615.0658047802893,CD74;LAPTM5
positive regulation of macromolecule metabolic process (GO:0010604),7/384,4.99526340044193e-4,0.0064046412884237605,0,0,5.499959810304638,41.80987074040145,CD74;DDX3X;LAPTM5;MMP8;HIF1A;SLC38A2;VSIR
antigen processing and presentation of exogenous peptide antigen (GO:0002478),4/103,5.497299286683276e-4,0.006965401566773986,0,0,11.610598741033524,87.15012292835831,CD74;HLA-DRA;HLA-A;HLA-E
regulation of receptor binding (GO:1900120),2/10,5.802192831152235e-4,0.007266234510640648,0,0,70.13732394366197,522.670663979618,B2M;MMP9
negative regulation of tumor necrosis factor production (GO:0032720),3/46,6.326999222538149e-4,0.00783238869272826,0,0,19.81794019933555,145.96932202772587,TNFAIP3;BPI;VSIR
regulation of DNA binding (GO:0051101),3/47,0.00067407505583561185,0.008249759490169931,0,0,19.366558441558443,141.41788451771782,NFKBIA;MMP8;MMP9
negative regulation of intracellular signal transduction (GO:1902532),5/198,7.871255546944953e-4,0.009525103622539005,0,0,7.51828710758915,53.734121101694186,DDX3X;PLEK;TNFAIP3;MMP9;MCL1
actin crosslink formation (GO:0051764),2/12,8.469756722727654e-4,0.010135475544864093,0,0,56.10422535211268,396.87223413076885,FLNA;LCP1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),4/119,9.449679231124647e-4,0.011102409609281725,0,0,9.987145557655955,69.55407278981167,DDX3X;LAPTM5;S100A9;S100A8
positive regulation of chemokine production (GO:0032722),3/53,9.587038938376977e-4,0.011102409609281725,0,0,17.03742857142857,118.40890692490767,CD74;DDX3X;HIF1A
positive regulation of NIK/NF-kappaB signaling (GO:1901224),3/53,9.587038938376977e-4,0.011102409609281725,0,0,17.03742857142857,118.40890692490767,DDX3X;LAPTM5;MMP8
cellular response to lipopolysaccharide (GO:0071222),4/120,9.748791232770678e-4,0.011169625699674491,0,0,9.90054972513743,68.64246235341662,TNFAIP3;DEFA3;BPI;PPBP
cytoplasmic sequestering of protein (GO:0051220),2/13,9.986092713926314e-4,0.011203147763436084,0,0,51.001280409731116,352.37534229207563,NFKBIA;FLNA
response to iron ion (GO:0010039),2/13,9.986092713926314e-4,0.011203147763436084,0,0,51.001280409731116,352.37534229207563,HIF1A;B2M
negative regulation of bone mineralization (GO:0030502),2/14,0.0011622956069068367,0.01251792368638663,0,0,46.748826291079816,315.89856738875534,SRGN;RFLNB
regulation of macrophage cytokine production (GO:0010935),2/14,0.0011622956069068367,0.01251792368638663,0,0,46.748826291079816,315.89856738875534,CD74;LAPTM5
detection of bacterium (GO:0016045),2/14,0.0011622956069068367,0.01251792368638663,0,0,46.748826291079816,315.89856738875534,HLA-B;HLA-A
positive regulation of regulatory T cell differentiation (GO:0045591),2/14,0.0011622956069068367,0.01251792368638663,0,0,46.748826291079816,315.89856738875534,HLA-DRA;VSIR
carboxylic acid transport (GO:0046942),3/57,0.001185024141232901,0.012636346535721132,0,0,15.772222222222222,106.27310924149687,SLC38A1;PSAP;SLC38A2
negative regulation of leukocyte activation (GO:0002695),2/15,0.0013379471101985043,0.01385547151619028,0,0,43.15059588299025,285.51104598113415,GRN;BPI
regulation of microglial cell activation (GO:1903978),2/15,0.0013379471101985043,0.01385547151619028,0,0,43.15059588299025,285.51104598113415,GRN;MMP8
glucan catabolic process (GO:0009251),2/15,0.0013379471101985043,0.01385547151619028,0,0,43.15059588299025,285.51104598113415,MGAM;PYGL
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),5/224,0.001363929869045603,0.0139900235139249,0,0,6.616975557346226,43.654736190873976,CD74;TNFAIP3;FLNA;S100A12;LTF
pattern recognition receptor signaling pathway (GO:0002221),3/61,0.00144246006243199,0.014655938558860878,0,0,14.68152709359606,96.03781835405219,FCN1;S100A9;S100A8
regulation of apoptotic process (GO:0042981),9/742,0.0014743399520966893,0.01466909267544035,0,0,3.6823414051841747,24.00719005254736,NFKBIA;CD74;DDX3X;STK17B;FLNA;OLFM4;MMP9;LTF;MCL1
negative regulation of macrophage activation (GO:0043031),2/16,0.0015254766756261087,0.01466909267544035,0,0,40.06639839034205,259.848557073974,GRN;BPI
cellular polysaccharide catabolic process (GO:0044247),2/16,0.0015254766756261087,0.01466909267544035,0,0,40.06639839034205,259.848557073974,MGAM;PYGL
epiboly involved in wound healing (GO:0090505),2/16,0.0015254766756261087,0.01466909267544035,0,0,40.06639839034205,259.848557073974,FLNA;LCP1
positive regulation of alpha-beta T cell proliferation (GO:0046641),2/16,0.0015254766756261087,0.01466909267544035,0,0,40.06639839034205,259.848557073974,HLA-A;HLA-E
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),2/16,0.0015254766756261087,0.01466909267544035,0,0,40.06639839034205,259.848557073974,CD74;LAPTM5
actin cytoskeleton reorganization (GO:0031532),3/63,0.0015833184581650439,0.015090566189767719,0,0,14.190714285714286,91.50502284857278,PLEK;MYH9;FLNA
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),3/64,0.0016568622589987344,0.01565298818369857,0,0,13.957377049180328,89.36670789604038,DDX3X;MMP9;MCL1
negative regulation of interleukin-10 production (GO:0032693),2/17,0.001724797657590095,0.01615310501934376,0,0,37.393427230046946,237.92112281582436,MMP8;VSIR
regulation of gene expression (GO:0010468),11/1079,0.001760597175026306,0.01633048575516234,0,0,3.1329134952277395,19.86925764408705,CD74;SFPQ;DDX3X;HNRNPDL;NFKBIZ;YBX1;MMP8;HIF1A;SLC38A2;VSIR;LTF
supramolecular fiber organization (GO:0097435),6/351,0.0017740639121207001,0.01633048575516234,0,0,5.0829331602855286,32.19775048469334,TPM3;FAT1;LYZ;B2M;ITM2B;LTF
cellular component disassembly (GO:0022411),3/66,0.0018102890593125907,0.01638387661243412,0,0,13.512925170068026,85.32424105728451,LCP1;MMP8;MMP9
extracellular matrix disassembly (GO:0022617),3/66,0.0018102890593125907,0.01638387661243412,0,0,13.512925170068026,85.32424105728451,LCP1;MMP8;MMP9
positive regulation of DNA-binding transcription factor activity (GO:0051091),5/246,0.0020566169127642004,0.018458136792058696,0,0,6.0062240663900415,37.15866391678015,NFKBIA;S100A12;S100A9;S100A8;LTF
regulation of neuroinflammatory response (GO:0150077),2/19,0.002158469583729576,0.0190546864071865,0,0,32.99088649544325,202.50980060332466,MMP8;MMP9
regulation of T cell cytokine production (GO:0002724),2/19,0.002158469583729576,0.0190546864071865,0,0,32.99088649544325,202.50980060332466,HLA-A;B2M
cortical actin cytoskeleton organization (GO:0030866),2/20,0.0023926495225994084,0.020781318837415828,0,0,31.156494522691705,188.04047198052453,PLEK;LCP1
glucose transmembrane transport (GO:1904659),2/20,0.0023926495225994084,0.020781318837415828,0,0,31.156494522691705,188.04047198052453,SLC2A3;PPBP
response to molecule of bacterial origin (GO:0002237),3/73,0.0024160566790904035,0.020816744347042917,0,0,12.157346938775511,73.25553510294327,TNFAIP3;S100A9;S100A8
integrin-mediated signaling pathway (GO:0007229),3/75,0.002609448046632313,0.022198643257130318,0,0,11.818452380952381,70.30344150433359,ITGB2;PLEK;MYH9
innate immune response in mucosa (GO:0002227),2/21,0.002638278864357178,0.022198643257130318,0,0,29.515196441808747,175.25027215896412,DEFA3;LTF
positive regulation of T cell cytokine production (GO:0002726),2/21,0.002638278864357178,0.022198643257130318,0,0,29.515196441808747,175.25027215896412,HLA-A;B2M
positive regulation of growth (GO:0045927),3/76,0.0027096258812793366,0.022622225380913533,0,0,11.655968688845402,68.89778640074914,DDX3X;S100A9;S100A8
negative regulation of B cell activation (GO:0050869),2/22,0.0028952732366765354,0.023270218476870365,0,0,28.038028169014083,163.87318444267802,LAPTM5;TNFAIP3
negative regulation of interleukin-2 production (GO:0032703),2/22,0.0028952732366765354,0.023270218476870365,0,0,28.038028169014083,163.87318444267802,LAPTM5;TNFAIP3
negative regulation of lymphocyte activation (GO:0051250),2/22,0.0028952732366765354,0.023270218476870365,0,0,28.038028169014083,163.87318444267802,LAPTM5;TNFAIP3
positive regulation of peptidase activity (GO:0010952),2/22,0.0028952732366765354,0.023270218476870365,0,0,28.038028169014083,163.87318444267802,GRN;VSIR
microglial cell activation (GO:0001774),2/22,0.0028952732366765354,0.023270218476870365,0,0,28.038028169014083,163.87318444267802,GRN;ITGB2
negative regulation of apoptotic signaling pathway (GO:2001234),3/78,0.0029170378201213514,0.023271479498301446,0,0,11.344,66.21704504863045,DDX3X;MMP9;MCL1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),3/80,0.003133977417490171,0.024511812710754102,0,0,11.048237476808906,63.69808662155511,DDX3X;TNFAIP3;MCL1
regulation of toll-like receptor 4 signaling pathway (GO:0034143),2/23,0.003163548715686927,0.024511812710754102,0,0,26.701542588866534,153.69570446963246,TNFAIP3;LTF
hexose transmembrane transport (GO:0008645),2/23,0.003163548715686927,0.024511812710754102,0,0,26.701542588866534,153.69570446963246,SLC2A3;PPBP
membrane protein ectodomain proteolysis (GO:0006509),2/23,0.003163548715686927,0.024511812710754102,0,0,26.701542588866534,153.69570446963246,MYH9;RBMX
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),3/81,0.0032460637702977184,0.024794401990146403,0,0,10.906043956043955,62.495036345416764,LAPTM5;S100A9;S100A8
regulation of interleukin-8 production (GO:0032677),3/81,0.0032460637702977184,0.024794401990146403,0,0,10.906043956043955,62.495036345416764,FCN1;CD74;BPI
positive regulation of neuron apoptotic process (GO:0043525),2/24,0.0034430218247567387,0.025750934064326443,0,0,25.486555697823302,144.54459867933434,GRN;MCL1
lymphocyte activation involved in immune response (GO:0002285),2/24,0.0034430218247567387,0.025750934064326443,0,0,25.486555697823302,144.54459867933434,CD74;LCP1
"wound healing, spreading of cells (GO:0044319)",2/24,0.0034430218247567387,0.025750934064326443,0,0,25.486555697823302,144.54459867933434,FLNA;LCP1
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),4/171,0.00355029408335857,0.02637011536398055,0,0,6.859324828603662,38.6915639363407,CD74;FLNA;S100A12;LTF
vascular transport (GO:0010232),3/84,0.003596992063211725,0.026533975699171423,0,0,10.5005291005291,59.0933794645851,SLC38A1;SLC2A3;SLC38A2
regulation of interferon-gamma production (GO:0032649),3/86,0.0038433323361367934,0.027968033283914367,0,0,10.246471600688468,56.98488590691847,LAPTM5;HLA-A;VSIR
transport across blood-brain barrier (GO:0150104),3/86,0.0038433323361367934,0.027968033283914367,0,0,10.246471600688468,56.98488590691847,SLC38A1;SLC2A3;SLC38A2
positive regulation of toll-like receptor signaling pathway (GO:0034123),2/27,0.004347798807470599,0.03135010234598812,0,0,22.424788732394365,121.94792031249217,DDX3X;LTF
positive regulation of binding (GO:0051099),3/90,0.004366309518939849,0.03135010234598812,0,0,9.773399014778326,53.10705845616846,MMP8;B2M;MMP9
toll-like receptor signaling pathway (GO:0002224),3/91,0.00450345336210517,0.0320440874461313,0,0,9.661850649350649,52.20211686113238,ITGB2;S100A9;S100A8
receptor clustering (GO:0043113),2/28,0.004671236517216912,0.0320440874461313,0,0,21.56121343445287,115.70461804458127,ITGB2;FLNA
regulation of B cell activation (GO:0050864),2/28,0.004671236517216912,0.0320440874461313,0,0,21.56121343445287,115.70461804458127,LAPTM5;TNFAIP3
neutral amino acid transport (GO:0015804),2/28,0.004671236517216912,0.0320440874461313,0,0,21.56121343445287,115.70461804458127,SLC38A1;SLC38A2
T cell activation involved in immune response (GO:0002286),2/28,0.004671236517216912,0.0320440874461313,0,0,21.56121343445287,115.70461804458127,CD74;LCP1
mucosal immune response (GO:0002385),2/28,0.004671236517216912,0.0320440874461313,0,0,21.56121343445287,115.70461804458127,DEFA3;LTF
protein localization to cell surface (GO:0034394),2/28,0.004671236517216912,0.0320440874461313,0,0,21.56121343445287,115.70461804458127,FCN1;FLNA
extracellular matrix organization (GO:0030198),5/300,0.004803740800832127,0.032744486344912664,0,0,4.893320039880359,26.122305588197,VCAN;ITGB2;LCP1;MMP8;MMP9
positive regulation of epithelial cell migration (GO:0010634),3/94,0.004930474158446077,0.0333969853373989,0,0,9.341915227629514,49.62724419848809,GRN;MMP9;HIF1A
negative regulation of interferon-gamma production (GO:0032689),2/29,0.00500546109415908,0.03369300999005831,0,0,20.761606677099635,109.97891737161149,LAPTM5;VSIR
plasma membrane invagination (GO:0099024),2/30,0.005350391696590665,0.035791129548000906,0,0,20.019114688128774,104.7116911394514,ITGB2;MYH9
negative regulation of interleukin-6 production (GO:0032715),2/31,0.005705947915146924,0.037244278209777194,0,0,19.327829043224867,99.85232246586659,TNFAIP3;BPI
regulation of cellular senescence (GO:2000772),2/31,0.005705947915146924,0.037244278209777194,0,0,19.327829043224867,99.85232246586659,YBX1;B2M
negative regulation of response to biotic stimulus (GO:0002832),2/31,0.005705947915146924,0.037244278209777194,0,0,19.327829043224867,99.85232246586659,TNFAIP3;LTF
positive regulation of RNA splicing (GO:0033120),2/31,0.005705947915146924,0.037244278209777194,0,0,19.327829043224867,99.85232246586659,SLC38A2;RBMX
regulation of macromolecule metabolic process (GO:0060255),4/200,0.0061707911267906,0.03989333617113181,0,0,5.835847382431234,29.692372629986004,HNRNPDL;NFKBIZ;YBX1;HIF1A
positive regulation of cell growth (GO:0030307),3/102,0.006185874782338917,0.03989333617113181,0,0,8.583549783549783,43.65152952506157,DDX3X;S100A9;S100A8
actin filament bundle organization (GO:0061572),2/33,0.006448617710717616,0.04110222617980732,0,0,18.07905497501136,91.18875518880436,RFLNB;LCP1
negative regulation of gene expression (GO:0010629),5/322,0.006449652947434947,0.04110222617980732,0,0,4.548617554277231,22.941994069284657,SRGN;DDX3X;YBX1;MMP8;HIF1A
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),2/34,0.006835572611732835,0.043052115221264696,0,0,17.513204225352112,87.31409431287084,DDX3X;TNFAIP3
positive regulation of DNA binding (GO:0043388),2/34,0.006835572611732835,0.043052115221264696,0,0,17.513204225352112,87.31409431287084,MMP8;MMP9
positive regulation of protein serine/threonine kinase activity (GO:0071902),3/106,0.006878708422138639,0.04307191262001927,0,0,8.248543689320389,41.07217464224149,DDX3X;S100A12;LTF
cellular response to virus (GO:0098586),2/35,0.007232835773441129,0.04502753831211616,0,0,16.9816474605207,83.70464769679762,DDX3X;HIF1A
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),2/36,0.007640328916095304,0.04729100139445196,0,0,16.48135874067937,80.33532794767753,FLNA;OLFM4
extracellular structure organization (GO:0043062),4/216,0.008056178117233264,0.04930930792138803,0,0,5.391030899644518,25.991863608022406,VCAN;ITGB2;MMP8;MMP9
"phagocytosis, engulfment (GO:0006911)",2/37,0.008057974182139549,0.04930930792138803,0,0,16.009657947686115,77.18405140445952,ITGB2;MYH9
external encapsulating structure organization (GO:0045229),4/217,0.008185212524935025,0.04980493722799447,0,0,5.365448731033545,25.783267388154467,VCAN;ITGB2;MMP8;MMP9
positive regulation of gene expression (GO:0010628),6/482,0.008290834005901518,0.050164203507617605,0,0,3.6594130189389187,17.538120074233273,CD74;DDX3X;MMP8;HIF1A;SLC38A2;VSIR
negative regulation of innate immune response (GO:0045824),2/38,0.008485694133689223,0.05077273656657385,0,0,15.564162754303599,74.23130658055668,GRN;TNFAIP3
positive regulation of production of molecular mediator of immune response (GO:0002702),2/38,0.008485694133689223,0.05077273656657385,0,0,15.564162754303599,74.23130658055668,LAPTM5;HLA-E
cellular response to molecule of bacterial origin (GO:0071219),3/115,0.008600859146169332,0.05117748784764846,0,0,7.582270408163265,36.060468123061995,TNFAIP3;DEFA3;PPBP
positive regulation of angiogenesis (GO:0045766),3/116,0.008806392706004166,0.05211255463937631,0,0,7.514791403286979,35.562077353403176,GRN;PKM;HIF1A
regulation of viral entry into host cell (GO:0046596),2/39,0.00892341174482248,0.05223105678898811,0,0,15.142748382185001,71.45979443987204,FCN1;CD74
membrane protein proteolysis (GO:0033619),2/39,0.00892341174482248,0.05223105678898811,0,0,15.142748382185001,71.45979443987204,MYH9;RBMX
positive regulation of protein-containing complex assembly (GO:0031334),3/118,0.009226077002968196,0.05371072936322566,0,0,7.383354037267081,34.596339629169705,DDX3X;PLEK;LCP1
carboxylic acid transmembrane transport (GO:1905039),2/41,0.009828533928940142,0.0565841392578906,0,0,14.364752618273744,66.40057337209727,SLC38A1;SLC38A2
cortical cytoskeleton organization (GO:0030865),2/41,0.009828533928940142,0.0565841392578906,0,0,14.364752618273744,66.40057337209727,PLEK;LCP1
protein homooligomerization (GO:0051260),3/121,0.009877268505555648,0.0565841392578906,0,0,7.19455205811138,33.22098278530106,RNF213;B2M;RBMX
regulation of chemokine production (GO:0032642),2/42,0.010295786519881377,0.05805529885817928,0,0,14.00492957746479,64.08684545227543,CD74;HIF1A
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),2/42,0.010295786519881377,0.05805529885817928,0,0,14.00492957746479,64.08684545227543,DDX3X;TNFAIP3
skeletal system morphogenesis (GO:0048705),2/42,0.010295786519881377,0.05805529885817928,0,0,14.00492957746479,64.08684545227543,RFLNB;LTF
positive regulation of T cell differentiation (GO:0045582),2/43,0.010772732804316568,0.06019082884546949,0,0,13.662658880109928,61.90191516841718,HLA-DRA;VSIR
cellular response to oxidative stress (GO:0034599),3/125,0.010786285949095274,0.06019082884546949,0,0,6.957259953161593,31.512768221410745,CYBB;MMP9;HIF1A
amino acid transmembrane transport (GO:0003333),2/45,0.011755406983254994,0.06526068722147231,0,0,13.025876187356697,57.87972501790881,SLC38A1;SLC38A2
interleukin-12-mediated signaling pathway (GO:0035722),2/46,0.012260986149212767,0.06771836965488282,0,0,12.729193341869399,56.02541764199213,HNRNPDL;LCP1
positive regulation of neuron death (GO:1901216),2/47,0.01277596155216492,0.0702026050596001,0,0,12.445696400625978,54.2655994638708,GRN;ITGB2
cellular response to interleukin-12 (GO:0071349),2/48,0.01330025983053789,0.07198180822858949,0,0,12.174525413349663,52.59360534174025,HNRNPDL;LCP1
regulation of interleukin-10 production (GO:0032653),2/48,0.01330025983053789,0.07198180822858949,0,0,12.174525413349663,52.59360534174025,MMP8;VSIR
regulation of interleukin-2 production (GO:0032663),2/48,0.01330025983053789,0.07198180822858949,0,0,12.174525413349663,52.59360534174025,LAPTM5;TNFAIP3
positive regulation of signal transduction (GO:0009967),4/252,0.01359178863859345,0.07319178181882573,0,0,4.600046750818139,19.77233239628701,CD74;TNFAIP3;FLNA;HIF1A
positive regulation of reactive oxygen species metabolic process (GO:2000379),2/49,0.013833808022784779,0.07412443403253337,0,0,11.914893617021276,51.00336814079256,ITGB2;MMP8
amino acid transport (GO:0006865),2/50,0.014376533555205991,0.07627353024116676,0,0,11.666079812206572,49.48935398933624,SLC38A1;SLC38A2
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/50,0.014376533555205991,0.07627353024116676,0,0,11.666079812206572,49.48935398933624,FLNA;OLFM4
regulation of interleukin-12 production (GO:0032655),2/51,0.014928364256672759,0.07842852831432469,0,0,11.42742167289451,48.046505681440294,HLA-B;LAPTM5
regulation of substrate adhesion-dependent cell spreading (GO:1900024),2/51,0.014928364256672759,0.07842852831432469,0,0,11.42742167289451,48.046505681440294,FLNA;OLFM4
negative regulation of DNA-binding transcription factor activity (GO:0043433),3/143,0.01546380448145711,0.08045660592526235,0,0,6.057244897959183,25.25418755661692,NFKBIA;TNFAIP3;FLNA
nitrogen compound transport (GO:0071705),3/143,0.01546380448145711,0.08045660592526235,0,0,6.057244897959183,25.25418755661692,SLC38A1;MYH9;SLC38A2
negative regulation of cysteine-type endopeptidase activity (GO:2000117),2/53,0.01605905442556056,0.08063666185134899,0,0,10.978182822424744,45.35616966163476,DDX3X;LTF
regulation of cell migration (GO:0030334),5/408,0.016685693813025457,0.08063666185134899,0,0,3.562253685593344,14.581029555136517,CD74;GRN;FLNA;MMP9;VSIR
positive regulation of cell migration (GO:0030335),4/269,0.01688038217669631,0.08063666185134899,0,0,4.301230516817063,17.5559160231814,GRN;MMP9;HIF1A;VSIR
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),2/55,0.017225308933891778,0.08063666185134899,0,0,10.562848790858357,42.89969557500649,DDX3X;MMP9
regulation of cytokine production (GO:0001817),3/150,0.017546342011646423,0.08063666185134899,0,0,5.766763848396502,23.31450597997171,SRGN;HLA-B;LTF
positive regulation of MAPK cascade (GO:0043410),4/274,0.017934506680253166,0.08063666185134899,0,0,4.220504562533548,16.97076986619746,CD74;LAPTM5;S100A12;MMP8
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,MMP9
antifungal humoral response (GO:0019732),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,LTF
regulation of cyclase activity (GO:0031279),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,CAP1
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,HIF1A
regulation of germinal center formation (GO:0002634),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,TNFAIP3
cellular response to nicotine (GO:0071316),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,B2M
negative regulation of transcription by RNA polymerase I (GO:0016479),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,FLNA
regulation of inflammatory response to wounding (GO:0106014),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,GRN
regulation of integrin biosynthetic process (GO:0045113),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,S100A9
chronic inflammatory response (GO:0002544),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,S100A9
regulation of lyase activity (GO:0051339),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,CAP1
CRD-mediated mRNA stabilization (GO:0070934),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,YBX1
regulation of natural killer cell mediated immunity (GO:0002715),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,HLA-E
regulation of neutrophil activation (GO:1902563),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,GRN
regulation of neutrophil degranulation (GO:0043313),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,ITGB2
regulation of plasma membrane organization (GO:1903729),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,MYH9
regulation of receptor catabolic process (GO:2000644),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,LAPTM5
regulation of respiratory burst involved in inflammatory response (GO:0060264),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,GRN
"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)",1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,HLA-DRA
glucose import across plasma membrane (GO:0098708),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,SLC2A3
ribose phosphate metabolic process (GO:0019693),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,TKT
positive regulation of membrane permeability (GO:1905710),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,LAPTM5
positive regulation of natural killer cell proliferation (GO:0032819),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,HLA-E
positive regulation of oxidative stress-induced neuron death (GO:1903223),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,MCL1
positive regulation of prostaglandin biosynthetic process (GO:0031394),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,CD74
mature ribosome assembly (GO:0042256),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,DDX3X
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,HIF1A
positive regulation of translation in response to stress (GO:0032056),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,DDX3X
protein K29-linked deubiquitination (GO:0035523),1/5,0.018118915662048707,0.08063666185134899,0,0,69.17708333333333,277.45536435713205,TNFAIP3
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/58,0.019040143053337656,0.0840419429034617,0,0,9.995472837022133,39.59412433945865,LAPTM5;TNFAIP3
positive regulation of protein binding (GO:0032092),2/58,0.019040143053337656,0.0840419429034617,0,0,9.995472837022133,39.59412433945865,B2M;MMP9
cellular response to interleukin-1 (GO:0071347),3/155,0.01912523891268305,0.08407298901616181,0,0,5.5756578947368425,22.061464342671105,NFKBIA;HIF1A;RBMX
positive regulation of apoptotic signaling pathway (GO:2001235),2/59,0.01966226345815744,0.08573383702200633,0,0,9.819619471213244,38.581815562195835,S100A9;S100A8
response to reactive oxygen species (GO:0000302),2/59,0.01966226345815744,0.08573383702200633,0,0,9.819619471213244,38.581815562195835,MMP9;HIF1A
T cell receptor signaling pathway (GO:0050852),3/158,0.020109251143246236,0.08625403977497757,0,0,5.466912442396313,21.35690519082458,NFKBIZ;HLA-DRA;HLA-A
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),2/60,0.020292856876402473,0.08625403977497757,0,0,9.64983001457018,37.61008059628398,PSAP;FLNA
positive regulation of interleukin-8 production (GO:0032757),2/61,0.02093185496883642,0.08625403977497757,0,0,9.485796132728575,36.67667061915704,FCN1;CD74
iron ion homeostasis (GO:0055072),2/61,0.02093185496883642,0.08625403977497757,0,0,9.485796132728575,36.67667061915704,LCN2;B2M
"negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)",1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,VSIR
astrocyte development (GO:0014002),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,S100A9
cellular response to cold (GO:0070417),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,NFKBIA
cellular response to iron ion (GO:0071281),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,B2M
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,TNFAIP3
regulation of hormone biosynthetic process (GO:0046885),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,HIF1A
regulation of macromolecule biosynthetic process (GO:0010556),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,S100A9
oxygen homeostasis (GO:0032364),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,HIF1A
"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,TKT
peptide antigen assembly with MHC protein complex (GO:0002501),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,HLA-DRA
regulation of neutrophil extravasation (GO:2000389),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,OLFM4
regulation of T-helper cell differentiation (GO:0045622),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,HLA-DRA
regulation of type 2 immune response (GO:0002828),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,CD74
glycolipid transport (GO:0046836),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,PSAP
hexose import across plasma membrane (GO:0140271),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,SLC2A3
positive regulation of microglial cell activation (GO:1903980),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,MMP8
positive regulation of osteoblast proliferation (GO:0033690),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,LTF
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,DDX3X
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,TNFAIP3
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),1/6,0.02170366274746418,0.08625403977497757,0,0,55.33888888888889,211.9631207182121,ITM2B
cellular response to reactive oxygen species (GO:0034614),2/63,0.022234793704465437,0.08803997360187234,0,0,9.173862849226506,34.91661125444899,TNFAIP3;MMP9
regulation of MAPK cascade (GO:0043408),3/166,0.022868047977986455,0.08809616821955818,0,0,5.196494303242769,19.632431489591283,CD74;LAPTM5;MMP8
regulation of innate immune response (GO:0045088),2/64,0.022898599528146314,0.08809616821955818,0,0,9.025442980463426,34.086205719817166,TNFAIP3;HLA-E
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),3/170,0.024321018938691142,0.08809616821955818,0,0,5.071000855431993,18.84594022431666,ITGB2;EMB;CEACAM8
positive regulation of catabolic process (GO:0009896),2/67,0.024938561718208668,0.08809616821955818,0,0,8.607583965330445,31.77351908127924,TNFAIP3;VSIR
regulation of viral genome replication (GO:0045069),2/67,0.024938561718208668,0.08809616821955818,0,0,8.607583965330445,31.77351908127924,DDX3X;LTF
aldehyde biosynthetic process (GO:0046184),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,TKT
astrocyte differentiation (GO:0048708),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,S100A9
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,FLNA
regulation of defense response to bacterium (GO:1900424),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,GRN
regulation of dopamine metabolic process (GO:0042053),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,ITGB2
regulation of inositol phosphate biosynthetic process (GO:0010919),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,PLEK
regulation of natural killer cell cytokine production (GO:0002727),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,HLA-E
regulation of natural killer cell proliferation (GO:0032817),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,HLA-E
regulation of necrotic cell death (GO:0010939),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,OLFM4
regulation of prostaglandin biosynthetic process (GO:0031392),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,CD74
polyamine biosynthetic process (GO:0006596),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,SAT1
regulation of T cell tolerance induction (GO:0002664),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,HLA-B
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,CD74
regulation of toll-like receptor 7 signaling pathway (GO:0034155),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,DDX3X
gas homeostasis (GO:0033483),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,HIF1A
positive regulation of cytoplasmic translation (GO:2000767),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,PKM
regulation of transforming growth factor beta2 production (GO:0032909),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,HIF1A
glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,TKT
positive regulation of fibroblast apoptotic process (GO:2000271),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,STK17B
response to host defenses (GO:0052200),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,B2M
positive regulation of hormone metabolic process (GO:0032352),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,HIF1A
positive regulation of integrin-mediated signaling pathway (GO:2001046),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,FLNA
ribose phosphate biosynthetic process (GO:0046390),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,TKT
positive regulation of natural killer cell cytokine production (GO:0002729),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,HLA-E
serine transport (GO:0032329),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,SLC38A2
iron import into cell (GO:0033212),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,LTF
positive regulation of oxidative stress-induced cell death (GO:1903209),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,SFPQ
positive regulation of podosome assembly (GO:0071803),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,LCP1
positive regulation of receptor catabolic process (GO:2000646),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,LAPTM5
positive regulation of T-helper 17 cell differentiation (GO:2000321),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,NFKBIZ
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,CD74
modulation by symbiont of host defense response (GO:0052031),1/7,0.025275502302547336,0.08809616821955818,0,0,46.113425925925924,169.6014749165987,B2M
positive regulation of cell-substrate adhesion (GO:0010811),2/70,0.027049956241546838,0.0935383579091005,0,0,8.226594863297432,29.69858242456063,FLNA;OLFM4
negative regulation of neuron apoptotic process (GO:0043524),2/71,0.027769323929047504,0.0935383579091005,0,0,8.10696060420494,29.05391449467342,GRN;HIF1A
myeloid leukocyte differentiation (GO:0002573),2/71,0.027769323929047504,0.0935383579091005,0,0,8.10696060420494,29.05391449467342,MYH9;MMP9
positive regulation of cellular biosynthetic process (GO:0031328),3/180,0.028167881194378307,0.0935383579091005,0,0,4.782082324455206,17.06999154214803,DDX3X;MMP8;HIF1A
extrinsic apoptotic signaling pathway (GO:0097191),2/72,0.028496368871475896,0.0935383579091005,0,0,7.9907444668008045,28.430897873617184,DDX3X;MCL1
"negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)",1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,VSIR
"regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,HLA-DRA
negative regulation of microglial cell activation (GO:1903979),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,GRN
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,DDX3X
regulation of chemokine-mediated signaling pathway (GO:0070099),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,HIF1A
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,NFKBIA
regulation of osteoclast development (GO:2001204),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,LTF
regulation of protein K63-linked ubiquitination (GO:1900044),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,DDX3X
positive regulation of aspartic-type peptidase activity (GO:1905247),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,GRN
"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,HLA-DRA
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,TNFAIP3
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,HIF1A
positive regulation of defense response to bacterium (GO:1900426),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,GRN
regulation of vascular wound healing (GO:0061043),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,TNFAIP3
positive regulation of isomerase activity (GO:0010912),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,ITGB2
RNA secondary structure unwinding (GO:0010501),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,DDX3X
spermidine metabolic process (GO:0008216),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,SAT1
T cell mediated cytotoxicity (GO:0001913),1/8,0.028834479875414456,0.0935383579091005,0,0,39.523809523809526,140.15867684434946,HLA-A
neurotransmitter transport (GO:0006836),2/73,0.029231027112912242,0.09453998859040985,0,0,7.877802023408054,27.828529138152547,SLC38A1;SLC38A2
regulation of cytokine-mediated signaling pathway (GO:0001959),2/74,0.02997323503031055,0.09665022193905527,0,0,7.767996870109546,27.24586420461107,CD74;TNFAIP3
antigen receptor-mediated signaling pathway (GO:0050851),3/185,0.030205915521887616,0.09710976423006855,0,0,4.6495290423861855,16.272038135821823,NFKBIZ;HLA-DRA;HLA-A
cellular response to oxygen-containing compound (GO:1901701),4/323,0.030453856692925482,0.0976154870782165,0,0,3.563309254463677,12.441446188155373,TNFAIP3;DEFA3;PPBP;MMP9
positive regulation of lymphocyte proliferation (GO:0050671),2/75,0.030722929375397234,0.09818574165371756,0,0,7.661200077175381,26.682014061706386,CD74;HLA-E
positive regulation of interleukin-6 production (GO:0032755),2/76,0.031480047231749624,0.098793060290065,0,0,7.5572896840502475,26.136140883906528,CD74;MMP8
positive regulation of tumor necrosis factor production (GO:0032760),2/77,0.03224452603513444,0.098793060290065,0,0,7.456150234741784,25.607454451072748,MMP8;HLA-E
cellular protein localization (GO:0034613),4/329,0.032267625409017044,0.098793060290065,0,0,3.4964548494983276,12.005745061641724,FCN1;CD74;LAPTM5;FLNA
negative regulation of bone resorption (GO:0045779),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,TNFAIP3
negative regulation of glycoprotein biosynthetic process (GO:0010561),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,ITM2B
negative regulation of leukocyte proliferation (GO:0070664),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,TNFAIP3
negative regulation of lipid localization (GO:1905953),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,NFKBIA
regulation of cellular extravasation (GO:0002691),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,OLFM4
regulation of fibroblast apoptotic process (GO:2000269),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,STK17B
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,LTF
positive regulation of memory T cell differentiation (GO:0043382),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,HLA-DRA
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,DDX3X
L-ascorbic acid metabolic process (GO:0019852),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,SLC2A3
lysosomal lumen acidification (GO:0007042),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,GRN
positive regulation of protein polyubiquitination (GO:1902916),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,DDX3X
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),1/9,0.03238064093072697,0.098793060290065,0,0,34.58159722222222,118.62160586885466,LAPTM5
negative regulation of NF-kappaB transcription factor activity (GO:0032088),2/79,0.033795317979728026,0.1012550031520014,0,0,7.261752332174868,24.598699541558176,NFKBIA;TNFAIP3
regulation of organelle organization (GO:0033043),2/80,0.03458150772275027,0.1012550031520014,0,0,7.168291802094619,24.117260421614933,S100A9;S100A8
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),2/81,0.03537481161931338,0.1012550031520014,0,0,7.077197361383491,23.65026142553085,MMP8;HLA-E
negative regulation of circadian rhythm (GO:0042754),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,SFPQ
B cell homeostasis (GO:0001782),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,TNFAIP3
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,LTF
negative regulation of receptor binding (GO:1900121),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,B2M
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,TNFAIP3
"complement activation, lectin pathway (GO:0001867)",1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,FCN1
nucleic acid transport (GO:0050657),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,YBX1
regulation of memory T cell differentiation (GO:0043380),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,HLA-DRA
defense response to tumor cell (GO:0002357),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,LAPTM5
regulation of neutrophil migration (GO:1902622),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,OLFM4
regulation of podosome assembly (GO:0071801),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,LCP1
positive regulation by symbiont of entry into host (GO:0075294),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,CD74
regulation of protein neddylation (GO:2000434),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,HIF1A
positive regulation of cell activation (GO:0050867),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,PLEK
regulation of T-helper 17 cell differentiation (GO:2000319),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,NFKBIZ
granulocyte migration (GO:0097530),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,ITGB2
positive regulation of keratinocyte migration (GO:0051549),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,MMP9
immunoglobulin mediated immune response (GO:0016064),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,CD74
positive regulation of monocyte differentiation (GO:0045657),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,CD74
secretory granule organization (GO:0033363),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,SRGN
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,LTF
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,HIF1A
positive regulation of viral entry into host cell (GO:0046598),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,CD74
modulation by symbiont of host process (GO:0044003),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,B2M
protein K11-linked deubiquitination (GO:0035871),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,TNFAIP3
negative regulation of alpha-beta T cell proliferation (GO:0046642),1/10,0.03591403083014349,0.1012550031520014,0,0,30.737654320987655,102.25271781730339,VSIR
regulation of angiogenesis (GO:0045765),3/203,0.03817039767262507,0.10412564199531549,0,0,4.227214285714286,13.804792530657686,GRN;TNFAIP3;HIF1A
actin filament network formation (GO:0051639),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,LCP1
negative regulation of bone remodeling (GO:0046851),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,TNFAIP3
regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,ITM2B
axonal transport of mitochondrion (GO:0019896),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,HIF1A
B cell mediated immunity (GO:0019724),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,CD74
negative regulation of interleukin-17 production (GO:0032700),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,VSIR
"regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,VSIR
negative regulation of natural killer cell mediated immunity (GO:0002716),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,HLA-E
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,MMP9
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,HIF1A
cellular glucan metabolic process (GO:0006073),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,PYGL
cellular response to UV-A (GO:0071492),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,MMP9
organophosphate catabolic process (GO:0046434),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,PLBD1
regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,TNFAIP3
Golgi to lysosome transport (GO:0090160),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,LAPTM5
positive regulation of integrin activation (GO:0033625),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,PLEK
positive regulation of interleukin-13 production (GO:0032736),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,HLA-E
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,NAMPT
positive regulation of vacuole organization (GO:0044090),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,GRN
monocyte differentiation (GO:0030224),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,MYH9
protein kinase C signaling (GO:0070528),1/11,0.039434694821538385,0.10412564199531549,0,0,27.6625,89.43588520720674,PLEK
negative regulation of cellular amide metabolic process (GO:0034249),2/86,0.0394459256583925,0.10412564199531549,0,0,6.654258886653253,21.51205126222182,DDX3X;YBX1
glucose homeostasis (GO:0042593),2/86,0.0394459256583925,0.10412564199531549,0,0,6.654258886653253,21.51205126222182,PYGL;HIF1A
positive regulation of endothelial cell migration (GO:0010595),2/86,0.0394459256583925,0.10412564199531549,0,0,6.654258886653253,21.51205126222182,GRN;HIF1A
response to interleukin-1 (GO:0070555),2/86,0.0394459256583925,0.10412564199531549,0,0,6.654258886653253,21.51205126222182,HIF1A;RBMX
negative regulation of inflammatory response (GO:0050728),3/212,0.04251667680159684,0.10831209419311467,0,0,4.043335611756665,12.76828328535709,GRN;TNFAIP3;MYH9
negative regulation of translation (GO:0017148),2/90,0.042824755206465094,0.10831209419311467,0,0,6.3505121638924455,20.00817098187963,DDX3X;YBX1
protein complex oligomerization (GO:0051259),2/90,0.042824755206465094,0.10831209419311467,0,0,6.3505121638924455,20.00817098187963,RNF213;RBMX
adipose tissue development (GO:0060612),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,NAMPT
regulation of actin filament depolymerization (GO:0030834),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,PLEK
regulation of axon regeneration (GO:0048679),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,GRN
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,HLA-DRA
regulation of dendritic cell differentiation (GO:2001198),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,HLA-B
regulation of keratinocyte migration (GO:0051547),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,MMP9
neurotransmitter uptake (GO:0001504),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,SLC38A1
dermatan sulfate biosynthetic process (GO:0030208),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,VCAN
positive regulation of actin filament depolymerization (GO:0030836),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,PLEK
positive regulation of cellular senescence (GO:2000774),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,B2M
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,ITGB2
positive regulation of neuroinflammatory response (GO:0150078),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,MMP8
positive regulation of protein depolymerization (GO:1901881),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,PLEK
positive regulation of T-helper 17 type immune response (GO:2000318),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,NFKBIZ
modulation by host of viral process (GO:0044788),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,LTF
negative regulation by host of viral process (GO:0044793),1/12,0.042942678013426154,0.10831209419311467,0,0,25.146464646464647,79.15828251915687,LTF
positive regulation of protein modification process (GO:0031401),3/214,0.04351503394291993,0.10949927933767468,0,0,4.004603926878809,12.553026864684114,CD74;DDX3X;MMP9
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),2/92,0.04455352704051626,0.10967928359488632,0,0,6.208763693270735,19.3158609487384,CD74;ITGB2
T cell activation (GO:0042110),2/92,0.04455352704051626,0.10967928359488632,0,0,6.208763693270735,19.3158609487384,CD74;LCP1
regulation of cell growth (GO:0001558),3/217,0.045034570537659045,0.10967928359488632,0,0,3.9478638184245662,12.239660300608248,DDX3X;S100A9;S100A8
regulation of epithelial cell proliferation (GO:0050678),2/93,0.04542755057999799,0.10967928359488632,0,0,6.140225971211887,18.983346835348595,GRN;B2M
cellular response to lipid (GO:0071396),3/219,0.04606220165823395,0.10967928359488632,0,0,3.9109126984126985,12.036860780067896,TNFAIP3;DEFA3;PPBP
negative regulation of cellular protein metabolic process (GO:0032269),2/94,0.04630792323592662,0.10967928359488632,0,0,6.073178199632578,18.659489014937357,DDX3X;YBX1
"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,VSIR
negative regulation of cellular senescence (GO:2000773),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,YBX1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,CD74
negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,NFKBIA
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,CD74
chondroitin sulfate catabolic process (GO:0030207),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,VCAN
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,ITGB2
regulation of lysosomal lumen pH (GO:0035751),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,GRN
dermatan sulfate metabolic process (GO:0030205),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,VCAN
pentose-phosphate shunt (GO:0006098),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,TKT
regulation of protein acetylation (GO:1901983),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,DDX3X
plasma membrane repair (GO:0001778),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,MYH9
polyamine metabolic process (GO:0006595),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,SAT1
regulation of response to stress (GO:0080134),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,SLC38A2
"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,HLA-DRA
positive regulation of cell aging (GO:0090343),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,B2M
glucose import (GO:0046323),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,SLC2A3
positive regulation of protein acetylation (GO:1901985),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,DDX3X
macrophage activation involved in immune response (GO:0002281),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,GRN
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,MMP8
mitochondrion transport along microtubule (GO:0047497),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,HIF1A
negative regulation of alcohol biosynthetic process (GO:1902931),1/13,0.04643802536608,0.10967928359488632,0,0,23.04976851851852,70.7544140609547,PLEK
positive regulation of cell motility (GO:2000147),3/221,0.04710146807071387,0.11100280330888149,0,0,3.8746395806028833,11.838771804364992,GRN;MMP9;VSIR
positive regulation of transcription by RNA polymerase II (GO:0045944),7/908,0.04744069893569979,0.11155815011735518,0,0,2.239632731308647,6.827015996742252,NFKBIA;SFPQ;DDX3X;NAMPT;YBX1;HIF1A;RBMX
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),2/98,0.04989177856548082,0.1129510124272009,0,0,5.818955399061033,17.444640851232034,CD74;HLA-DRA
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,CD74
bone morphogenesis (GO:0060349),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,LTF
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,RBMX
negative regulation of neuroinflammatory response (GO:0150079),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,GRN
negative regulation of secretion (GO:0051048),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,CD74
cellular response to low-density lipoprotein particle stimulus (GO:0071404),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,ITGB2
ceramide transport (GO:0035627),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,PSAP
regulation of integrin-mediated signaling pathway (GO:2001044),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,FLNA
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,CD74
cytoplasmic sequestering of transcription factor (GO:0042994),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,NFKBIA
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,NAMPT
response to UV-A (GO:0070141),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,MMP9
positive regulation of leukocyte degranulation (GO:0043302),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,ITGB2
positive regulation of superoxide anion generation (GO:0032930),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,ITGB2
positive regulation of T-helper cell differentiation (GO:0045624),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,NFKBIZ
positive regulation of type 2 immune response (GO:0002830),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,CD74
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/14,0.04992078172269975,0.1129510124272009,0,0,21.275641025641026,63.76985958511893,NAMPT
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),2/100,0.05172034528607497,0.11470746186310793,0,0,5.699626329405001,16.881746303056282,CD74;HLA-DRA
organic acid transport (GO:0015849),2/100,0.05172034528607497,0.11470746186310793,0,0,5.699626329405001,16.881746303056282,SLC38A1;SLC38A2
positive regulation of translation (GO:0045727),2/100,0.05172034528607497,0.11470746186310793,0,0,5.699626329405001,16.881746303056282,DDX3X;PKM
cellular response to chemical stress (GO:0062197),2/101,0.052643595660352066,0.11470746186310793,0,0,5.641769810783895,16.610558974341643,DDX3X;CYBB
negative regulation of chondrocyte differentiation (GO:0032331),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,RFLNB
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,HLA-E
negative regulation of mRNA processing (GO:0050686),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,RBMX
regulation of cytoplasmic translation (GO:2000765),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,PKM
cellular response to arsenic-containing substance (GO:0071243),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,DDX3X
regulation of integrin activation (GO:0033623),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,PLEK
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,VCAN
regulation of non-canonical Wnt signaling pathway (GO:2000050),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,RNF213
regulation of superoxide anion generation (GO:0032928),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,ITGB2
glycogen catabolic process (GO:0005980),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,PYGL
histone H3 deacetylation (GO:0070932),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,SFPQ
positive regulation of natural killer cell activation (GO:0032816),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,HLA-E
superoxide anion generation (GO:0042554),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,CYBB
macrophage differentiation (GO:0030225),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,MMP9
positive regulation of response to cytokine stimulus (GO:0060760),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,CD74
positive regulation of sprouting angiogenesis (GO:1903672),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,PKM
prostanoid biosynthetic process (GO:0046457),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,CD74
protein kinase A signaling (GO:0010737),1/15,0.05339099174661933,0.11470746186310793,0,0,19.754960317460316,57.88427080418689,LCP1
cell junction assembly (GO:0034329),2/102,0.05357275145510054,0.11470746186310793,0,0,5.585070422535211,16.34590775388441,FLNA;TLN1
regulation of protein catabolic process (GO:0042176),2/102,0.05357275145510054,0.11470746186310793,0,0,5.585070422535211,16.34590775388441,TNFAIP3;FLNA
positive regulation of cellular protein metabolic process (GO:0032270),2/102,0.05357275145510054,0.11470746186310793,0,0,5.585070422535211,16.34590775388441,NFKBIA;DDX3X
intrinsic apoptotic signaling pathway (GO:0097193),2/102,0.05357275145510054,0.11470746186310793,0,0,5.585070422535211,16.34590775388441,DDX3X;MCL1
positive regulation of vasculature development (GO:1904018),2/102,0.05357275145510054,0.11470746186310793,0,0,5.585070422535211,16.34590775388441,GRN;HIF1A
negative regulation of anoikis (GO:2000811),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,MCL1
negative regulation of epithelial cell differentiation (GO:0030857),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,MMP9
negative regulation of immune effector process (GO:0002698),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,GRN
regulation of defense response to virus (GO:0050688),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,TNFAIP3
regulation of interleukin-13 production (GO:0032656),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,HLA-E
regulation of leukocyte activation (GO:0002694),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,CD74
dendrite self-avoidance (GO:0070593),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,EMB
regulation of monocyte differentiation (GO:0045655),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,CD74
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,ITGB2
T cell mediated immunity (GO:0002456),1/16,0.056848699968537475,0.11934902508014594,0,0,18.437037037037037,52.8656580429068,HLA-A
protein processing (GO:0016485),2/106,0.05734735211464239,0.12016166970324875,0,0,5.369176598049838,15.348481819745821,SRGN;VSIR
regulation of protein ubiquitination (GO:0031396),2/109,0.06023769075329709,0.12345358363994197,0,0,5.21784915098065,14.659322980444273,LAPTM5;TNFAIP3
negative regulation of ATPase activity (GO:0032780),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,LTF
negative regulation of cell aging (GO:0090344),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,YBX1
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,CD74
cellular biogenic amine biosynthetic process (GO:0042401),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,SAT1
negative regulation of viral entry into host cell (GO:0046597),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,FCN1
regulation of NLRP3 inflammasome complex assembly (GO:1900225),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,DDX3X
regulation of osteoblast proliferation (GO:0033688),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,LTF
positive regulation of collagen metabolic process (GO:0010714),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,VSIR
positive regulation of cytokine production involved in inflammatory response (GO:1900017),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,HIF1A
positive regulation of macrophage activation (GO:0043032),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,MMP8
ruffle organization (GO:0031529),1/17,0.06029395078422422,0.12345358363994197,0,0,17.283854166666668,48.54211057952261,PLEK
regulation of protein serine/threonine kinase activity (GO:0071900),2/111,0.06219207728289913,0.1266305371156088,0,0,5.121591936942758,14.225363279476147,DDX3X;LTF
regulation of cytoskeleton organization (GO:0051493),2/112,0.06317736381740657,0.1266305371156088,0,0,5.074775928297055,14.015562894578204,S100A9;S100A8
phosphatidylinositol metabolic process (GO:0046488),2/112,0.06317736381740657,0.1266305371156088,0,0,5.074775928297055,14.015562894578204,PLEK;PLBD1
negative regulation of cation transmembrane transport (GO:1904063),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,MMP9
"alternative mRNA splicing, via spliceosome (GO:0000380)",1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,SFPQ
negative regulation of interleukin-8 production (GO:0032717),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,BPI
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,LAPTM5
negative regulation of signal transduction by p53 class mediator (GO:1901797),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,CD74
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,SFPQ
phosphatidylinositol acyl-chain remodeling (GO:0036149),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,PLBD1
regulation of transcription by RNA polymerase I (GO:0006356),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,FLNA
regulation of transforming growth factor beta production (GO:0071634),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,HIF1A
positive regulation of interleukin-4 production (GO:0032753),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,HLA-E
intracellular estrogen receptor signaling pathway (GO:0030520),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,DEFA3
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,RBMX
positive regulation of nitric-oxide synthase activity (GO:0051000),1/18,0.06372678840915502,0.1266305371156088,0,0,16.266339869281047,44.783677915691136,HIF1A
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",3/251,0.06405385407060005,0.12704604205163214,0,0,3.400748847926267,9.34536352803777,SFPQ;YBX1;RBMX
response to lipid (GO:0033993),2/114,0.0651638680782169,0.12898804177601944,0,0,4.9836519114688125,13.609606491431535,S100A9;S100A8
positive regulation of phosphorylation (GO:0042327),3/253,0.06527250024877493,0.12898804177601944,0,0,3.3732,9.206085023241963,CD74;MMP9;HIF1A
"positive regulation of transcription, DNA-templated (GO:0045893)",8/1183,0.06595557471569391,0.13009918309304458,0,0,1.96420294599018,5.340223652722162,NFKBIA;CD74;SFPQ;DDX3X;NAMPT;YBX1;HIF1A;RBMX
positive regulation of protein metabolic process (GO:0051247),2/115,0.06616498455804216,0.1302736533254322,0,0,4.939299513897544,13.413180974520342,NFKBIA;TNFAIP3
actin filament capping (GO:0051693),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,ADD3
barbed-end actin filament capping (GO:0051016),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,ADD3
negative regulation of nervous system development (GO:0051961),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,B2M
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,HIF1A
negative regulation of RNA splicing (GO:0033119),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,RBMX
negative regulation of T cell receptor signaling pathway (GO:0050860),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,LAPTM5
positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,CD74
prostaglandin biosynthetic process (GO:0001516),1/19,0.06714725693918218,0.13030197427657514,0,0,15.361882716049383,41.49040525939519,CD74
regulation of cellular response to stress (GO:0080135),2/118,0.06919918988758013,0.13331257212153275,0,0,4.810830500242837,12.848603124765257,SLC38A2;MCL1
negative regulation of response to external stimulus (GO:0032102),2/118,0.06919918988758013,0.13331257212153275,0,0,4.810830500242837,12.848603124765257,TNFAIP3;LTF
cellular component assembly (GO:0022607),3/261,0.07025382431021929,0.13331257212153275,0,0,3.2672757475083056,8.676709909761225,CD74;FLNA;LCP1
protein targeting to lysosome (GO:0006622),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,LAPTM5
negative regulation of lipid storage (GO:0010888),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,NFKBIA
negative regulation of osteoclast differentiation (GO:0045671),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,LTF
negative regulation of viral life cycle (GO:1903901),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,FCN1
energy reserve metabolic process (GO:0006112),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,PYGL
regulation of protein modification by small protein conjugation or removal (GO:1903320),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,HIF1A
positive regulation of interferon-alpha production (GO:0032727),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,DDX3X
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,HLA-E
lipopolysaccharide-mediated signaling pathway (GO:0031663),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,BPI
positive regulation of protein processing (GO:0010954),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,MYH9
maintenance of protein location in nucleus (GO:0051457),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,SYNE1
toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.07055540028716217,0.13331257212153275,0,0,14.552631578947368,38.5842224505161,ITGB2
regulation of protein phosphorylation (GO:0001932),3/266,0.0734526027895043,0.13618744738650543,0,0,3.20434546442151,8.366914317577193,CD74;ITGB2;MMP9
regulation of anoikis (GO:2000209),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,MCL1
negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,MMP9
chondroitin sulfate biosynthetic process (GO:0030206),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,VCAN
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,LTF
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,MCL1
positive regulation of glycolytic process (GO:0045821),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,HIF1A
positive regulation of phosphatase activity (GO:0010922),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,PLEK
stress granule assembly (GO:0034063),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,DDX3X
positive regulation of purine nucleotide metabolic process (GO:1900544),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,HIF1A
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,HIF1A
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,MMP9
vacuolar acidification (GO:0007035),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,GRN
NAD biosynthetic process (GO:0009435),1/21,0.07395126223609223,0.13618744738650543,0,0,13.824305555555556,36.00331664229168,NAMPT
negative regulation of signal transduction (GO:0009968),3/267,0.07410013386118122,0.13618744738650543,0,0,3.1920454545454544,8.306780993168458,PLEK;TNFAIP3;LTF
protein deubiquitination (GO:0016579),3/267,0.07410013386118122,0.13618744738650543,0,0,3.1920454545454544,8.306780993168458,NFKBIA;TNFAIP3;HIF1A
positive regulation of epithelial cell proliferation (GO:0050679),2/123,0.07435609161103306,0.1364250607582327,0,0,4.610871842626004,11.983147237820289,GRN;HIF1A
negative regulation of biomineral tissue development (GO:0070168),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,SRGN
regulation of adenylate cyclase activity (GO:0045761),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,CAP1
regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,FLNA
negative regulation of phosphate metabolic process (GO:0045936),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,PLEK
cellular response to osmotic stress (GO:0071470),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,DDX3X
regulation of lipid storage (GO:0010883),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,NFKBIA
regulation of platelet activation (GO:0010543),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,PLEK
positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,CD74
positive regulation of neutrophil migration (GO:1902624),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,CD74
positive regulation of translational initiation (GO:0045948),1/22,0.07733488642276296,0.1395136895767432,0,0,13.165343915343914,33.69814742858341,DDX3X
positive regulation of cellular process (GO:0048522),5/625,0.07805029926958337,0.14056885002230984,0,0,2.2897296015180264,5.839730491950285,GRN;DDX3X;NAMPT;S100A9;S100A8
"mRNA splicing, via spliceosome (GO:0000398)",3/274,0.07870442003481694,0.14133447588101847,0,0,3.108487084870849,7.901948127052975,SFPQ;YBX1;RBMX
protein modification by small protein removal (GO:0070646),3/276,0.0800426824343233,0.14133447588101847,0,0,3.0854003139717427,7.791238236183585,NFKBIA;TNFAIP3;HIF1A
cellular response to insulin stimulus (GO:0032869),2/129,0.08070176135371906,0.14133447588101847,0,0,4.391704558057003,11.053897878318477,PKM;NAMPT
positive regulation of macromolecule biosynthetic process (GO:0010557),2/129,0.08070176135371906,0.14133447588101847,0,0,4.391704558057003,11.053897878318477,DDX3X;NAMPT
muscle contraction (GO:0006936),2/129,0.08070176135371906,0.14133447588101847,0,0,4.391704558057003,11.053897878318477,TPM3;TLN1
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,MCL1
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,PLEK
blood vessel endothelial cell migration (GO:0043534),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,MYH9
regulation of cysteine-type endopeptidase activity (GO:2000116),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,LTF
negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,MCL1
regulation of interleukin-4 production (GO:0032673),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,HLA-E
cytoskeleton-dependent intracellular transport (GO:0030705),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,TUBA1A
positive regulation of cholesterol efflux (GO:0010875),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,NFKBIA
glucose 6-phosphate metabolic process (GO:0051156),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,TKT
positive regulation of mRNA processing (GO:0050685),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,RBMX
positive regulation of natural killer cell mediated immunity (GO:0002717),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,HLA-E
positive regulation of protein autophosphorylation (GO:0031954),1/23,0.08070631631088798,0.14133447588101847,0,0,12.566287878787879,31.62857298179009,DDX3X
cellular response to metal ion (GO:0071248),2/131,0.08285350374808254,0.1434843836299065,0,0,4.3231793863958945,10.76766181968016,B2M;MMP9
regulation of cell size (GO:0008361),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,PLEK
canonical glycolysis (GO:0061621),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,PKM
negative regulation of neuron differentiation (GO:0045665),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,B2M
negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,DDX3X
regulation of cytokine production involved in immune response (GO:0002718),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,LAPTM5
negative regulation of ossification (GO:0030279),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,SRGN
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,TNFAIP3
phospholipid catabolic process (GO:0009395),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,PLBD1
positive regulation of carbohydrate metabolic process (GO:0045913),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,HIF1A
glucose catabolic process to pyruvate (GO:0061718),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,PKM
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,HIF1A
positive regulation of protein targeting to membrane (GO:0090314),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,ITGB2
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,HIF1A
positive regulation of viral life cycle (GO:1903902),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,CD74
protein K48-linked deubiquitination (GO:0071108),1/24,0.08406559523720614,0.1434843836299065,0,0,12.019323671497585,29.76174313200534,TNFAIP3
RNA metabolic process (GO:0016070),2/133,0.08502289030340904,0.1448886912290689,0,0,4.2567465863885605,10.492176955148778,DDX3X;RBMX
positive regulation of programmed cell death (GO:0043068),3/286,0.08688241047547969,0.14664104264142985,0,0,2.974861181221605,7.268179880941477,DDX3X;STK17B;LAPTM5
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,LAPTM5
negative regulation of cellular carbohydrate metabolic process (GO:0010677),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,PLEK
cAMP-mediated signaling (GO:0019933),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,CAP1
regulation of interferon-alpha production (GO:0032647),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,DDX3X
regulation of neutrophil chemotaxis (GO:0090022),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,CD74
positive regulation of ERBB signaling pathway (GO:1901186),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,MMP9
glycolytic process through glucose-6-phosphate (GO:0061620),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,PKM
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,MMP9
positive regulation of vascular endothelial growth factor production (GO:0010575),1/25,0.08741276636564344,0.14664104264142985,0,0,11.517939814814815,28.070531668147478,HIF1A
proteolysis (GO:0006508),3/287,0.08757977921970395,0.14669272506939526,0,0,2.964235412474849,7.218521308213911,SRGN;MMP8;MMP9
regulation of actin filament bundle assembly (GO:0032231),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,PLEK
negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,TNFAIP3
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,CD74
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,PLBD1
regulation of regulatory T cell differentiation (GO:0045589),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,VSIR
glial cell development (GO:0021782),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,S100A9
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,DDX3X
mononuclear cell differentiation (GO:1903131),1/26,0.09074787272717313,0.15013127331361822,0,0,11.056666666666667,26.53235403248719,MYH9
positive regulation of cellular catabolic process (GO:0031331),2/141,0.0938696842422767,0.1530429318834561,0,0,4.010132738879319,9.48736370361186,LAPTM5;HIF1A
negative regulation of cation channel activity (GO:2001258),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,MMP9
negative regulation of endothelial cell apoptotic process (GO:2000352),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,TNFAIP3
cellular lipid catabolic process (GO:0044242),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,PLBD1
cellular response to cadmium ion (GO:0071276),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,MMP9
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,VCAN
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,TNFAIP3
regulation of vascular endothelial growth factor production (GO:0010574),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,HIF1A
positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,HIF1A
positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,MMP8
L-alpha-amino acid transmembrane transport (GO:1902475),1/27,0.09407095720227293,0.1530429318834561,0,0,10.630876068376068,25.12826467235412,SLC38A1
protein localization to organelle (GO:0033365),2/142,0.09499384599585246,0.15378369696479285,0,0,3.9812877263581488,9.371725045177696,DDX3X;YBX1
positive regulation of cell population proliferation (GO:0008284),4/474,0.09503674955317065,0.15378369696479285,0,0,2.3998766574159727,5.648089613738546,CD74;GRN;NAMPT;LTF
mRNA processing (GO:0006397),3/300,0.09686068868617188,0.15378369696479285,0,0,2.832611832611833,6.612680010310167,SFPQ;YBX1;RBMX
regulation of calcium-mediated signaling (GO:0050848),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,PLEK
carbohydrate derivative biosynthetic process (GO:1901137),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,TKT
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,CD74
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,MCL1
regulation of immunoglobulin production (GO:0002637),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,HLA-E
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,TNFAIP3
regulation of protein transport (GO:0051223),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,LCP1
regulation of reactive oxygen species biosynthetic process (GO:1903426),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,MMP8
glycogen metabolic process (GO:0005977),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,PYGL
positive regulation of fibroblast proliferation (GO:0048146),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,CD74
positive regulation of monooxygenase activity (GO:0032770),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,HIF1A
positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,MMP8
L-amino acid transport (GO:0015807),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,SLC38A2
leukocyte cell-cell adhesion (GO:0007159),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,ITGB2
positive regulation of protein import into nucleus (GO:0042307),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,FLNA
positive regulation of response to wounding (GO:1903036),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,GRN
protein localization to lysosome (GO:0061462),1/28,0.09738206251623838,0.15378369696479285,0,0,10.236625514403292,23.842260104213242,LAPTM5
negative regulation of mRNA catabolic process (GO:1902373),1/29,0.10068123124553315,0.15760710181895232,0,0,9.870535714285714,22.660735221252363,YBX1
regulation of protein targeting to membrane (GO:0090313),1/29,0.10068123124553315,0.15760710181895232,0,0,9.870535714285714,22.660735221252363,ITGB2
glycolytic process (GO:0006096),1/29,0.10068123124553315,0.15760710181895232,0,0,9.870535714285714,22.660735221252363,PKM
response to cadmium ion (GO:0046686),1/29,0.10068123124553315,0.15760710181895232,0,0,9.870535714285714,22.660735221252363,MMP9
transition metal ion homeostasis (GO:0055076),1/29,0.10068123124553315,0.15760710181895232,0,0,9.870535714285714,22.660735221252363,B2M
positive regulation of viral genome replication (GO:0045070),1/29,0.10068123124553315,0.15760710181895232,0,0,9.870535714285714,22.660735221252363,DDX3X
positive regulation of intracellular protein transport (GO:0090316),2/148,0.10181975736200229,0.15915802420736785,0,0,3.816515531545437,8.719024807358487,ITGB2;FLNA
negative regulation of interleukin-1 production (GO:0032692),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,TNFAIP3
cell projection organization (GO:0030030),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,PLEK
chondroitin sulfate metabolic process (GO:0030204),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,VCAN
regulation of natural killer cell mediated cytotoxicity (GO:0042269),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,HLA-E
phosphatidylcholine acyl-chain remodeling (GO:0036151),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,PLBD1
positive regulation of B cell proliferation (GO:0030890),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,CD74
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,DDX3X
positive regulation of endopeptidase activity (GO:0010950),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,VSIR
heterotypic cell-cell adhesion (GO:0034113),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,ITGB2
positive regulation of protein import (GO:1904591),1/30,0.10396850581271733,0.16018760281387376,0,0,9.529693486590038,21.572055090315498,FLNA
response to cytokine (GO:0034097),2/150,0.10412488881383138,0.16018760281387376,0,0,3.7645603349828702,8.516053792875216,CD74;MCL1
positive regulation of apoptotic process (GO:0043065),3/310,0.10426324008591041,0.16018760281387376,0,0,2.7389483480688694,6.192314186427725,GRN;DDX3X;STK17B
negative regulation of DNA binding (GO:0043392),1/31,0.10724392850313601,0.16313800988400773,0,0,9.211574074074074,20.566214716689423,NFKBIA
negative regulation of response to DNA damage stimulus (GO:2001021),1/31,0.10724392850313601,0.16313800988400773,0,0,9.211574074074074,20.566214716689423,CD74
regulation of macrophage derived foam cell differentiation (GO:0010743),1/31,0.10724392850313601,0.16313800988400773,0,0,9.211574074074074,20.566214716689423,NFKBIA
peptide cross-linking (GO:0018149),1/31,0.10724392850313601,0.16313800988400773,0,0,9.211574074074074,20.566214716689423,F13A1
positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/31,0.10724392850313601,0.16313800988400773,0,0,9.211574074074074,20.566214716689423,ITGB2
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),1/31,0.10724392850313601,0.16313800988400773,0,0,9.211574074074074,20.566214716689423,LAPTM5
prostaglandin metabolic process (GO:0006693),1/31,0.10724392850313601,0.16313800988400773,0,0,9.211574074074074,20.566214716689423,CD74
positive regulation of Wnt signaling pathway (GO:0030177),2/153,0.10760941601938567,0.16346310444693707,0,0,3.6892080962596774,8.224156544361588,DDX3X;TNFAIP3
positive regulation of protein kinase activity (GO:0045860),2/154,0.1087779177985723,0.16500537671698923,0,0,3.66475166790215,8.13005707429955,DDX3X;LTF
regulation of intracellular protein transport (GO:0033157),1/32,0.11050754144475816,0.16645681417623012,0,0,8.913978494623656,19.634566488548145,LCP1
hematopoietic progenitor cell differentiation (GO:0002244),1/32,0.11050754144475816,0.16645681417623012,0,0,8.913978494623656,19.634566488548145,PLEK
positive regulation of immune effector process (GO:0002699),1/32,0.11050754144475816,0.16645681417623012,0,0,8.913978494623656,19.634566488548145,HLA-DRA
superoxide metabolic process (GO:0006801),1/32,0.11050754144475816,0.16645681417623012,0,0,8.913978494623656,19.634566488548145,CYBB
protein K63-linked deubiquitination (GO:0070536),1/32,0.11050754144475816,0.16645681417623012,0,0,8.913978494623656,19.634566488548145,TNFAIP3
skeletal system development (GO:0001501),2/158,0.11348582495380964,0.1687587595291543,0,0,3.570061394005056,7.768729702384903,VCAN;RFLNB
actin filament bundle assembly (GO:0051017),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,LCP1
apoptotic cell clearance (GO:0043277),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,FCN1
regulation of cholesterol efflux (GO:0010874),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,NFKBIA
negative regulation of smooth muscle cell proliferation (GO:0048662),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,TNFAIP3
regulation of interleukin-17 production (GO:0032660),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,VSIR
positive regulation of ATP metabolic process (GO:1903580),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,HIF1A
regulation of sprouting angiogenesis (GO:1903670),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,PKM
positive regulation of cholesterol transport (GO:0032376),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,NFKBIA
RNA stabilization (GO:0043489),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,YBX1
lytic vacuole organization (GO:0080171),1/33,0.1137593866463937,0.1687587595291543,0,0,8.63498263888889,18.769600161790645,GRN
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/34,0.11699950591866148,0.17285112191275503,0,0,8.372895622895623,17.964764003409375,MMP9
positive regulation of interleukin-12 production (GO:0032735),1/34,0.11699950591866148,0.17285112191275503,0,0,8.372895622895623,17.964764003409375,LAPTM5
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.11699950591866148,0.17285112191275503,0,0,8.372895622895623,17.964764003409375,HIF1A
negative regulation of neurogenesis (GO:0050768),1/35,0.12022794098244914,0.1759313755952415,0,0,8.126225490196079,17.21431840365986,B2M
cellular response to hydrogen peroxide (GO:0070301),1/35,0.12022794098244914,0.1759313755952415,0,0,8.126225490196079,17.21431840365986,TNFAIP3
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.12022794098244914,0.1759313755952415,0,0,8.126225490196079,17.21431840365986,DDX3X
regulation of T cell receptor signaling pathway (GO:0050856),1/35,0.12022794098244914,0.1759313755952415,0,0,8.126225490196079,17.21431840365986,LAPTM5
positive regulation of immunoglobulin production (GO:0002639),1/35,0.12022794098244914,0.1759313755952415,0,0,8.126225490196079,17.21431840365986,HLA-E
semaphorin-plexin signaling pathway (GO:0071526),1/35,0.12022794098244914,0.1759313755952415,0,0,8.126225490196079,17.21431840365986,FLNA
muscle cell differentiation (GO:0042692),1/35,0.12022794098244914,0.1759313755952415,0,0,8.126225490196079,17.21431840365986,SYNE1
activation of adenylate cyclase activity (GO:0007190),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,CAP1
axonal transport (GO:0098930),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,HIF1A
regulation of defense response to virus by host (GO:0050691),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,TNFAIP3
negative regulation of toll-like receptor signaling pathway (GO:0034122),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,TNFAIP3
cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,CAP1
regulation of protein import into nucleus (GO:0042306),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,FLNA
positive regulation of bone mineralization (GO:0030501),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,LTF
positive regulation of innate immune response (GO:0045089),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,HLA-E
positive regulation of interferon-beta production (GO:0032728),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,DDX3X
positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,CD74
macrophage activation (GO:0042116),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,ITGB2
transition metal ion transport (GO:0000041),1/36,0.12344473334823387,0.17774061205353997,0,0,7.893650793650794,16.51321534130612,LTF
negative regulation of epithelial cell apoptotic process (GO:1904036),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,TNFAIP3
regulation of erythrocyte differentiation (GO:0045646),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,HIF1A
regulation of protein autophosphorylation (GO:0031952),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,DDX3X
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,MMP9
positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,HIF1A
lysosome localization (GO:0032418),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,MYH9
positive regulation of signaling receptor activity (GO:2000273),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,HIF1A
tRNA transport (GO:0051031),1/37,0.12664992444548392,0.1804258844282886,0,0,7.673996913580247,15.85699852450674,YBX1
actin-myosin filament sliding (GO:0033275),1/38,0.12984355553611984,0.18376019620552048,0,0,7.466216216216216,15.241720231400874,TPM3
connective tissue development (GO:0061448),1/38,0.12984355553611984,0.18376019620552048,0,0,7.466216216216216,15.241720231400874,NAMPT
positive regulation of potassium ion transport (GO:0043268),1/38,0.12984355553611984,0.18376019620552048,0,0,7.466216216216216,15.241720231400874,FLNA
lysosome organization (GO:0007040),1/38,0.12984355553611984,0.18376019620552048,0,0,7.466216216216216,15.241720231400874,GRN
muscle filament sliding (GO:0030049),1/38,0.12984355553611984,0.18376019620552048,0,0,7.466216216216216,15.241720231400874,TPM3
post-translational protein modification (GO:0043687),3/345,0.13183124631473542,0.18632841506688982,0,0,2.4542606516290726,4.972902968968828,VCAN;APLP2;HIF1A
regulation of intracellular transport (GO:0032386),1/39,0.1330256677214299,0.18654771371872397,0,0,7.269371345029239,14.663871680193896,LCP1
organophosphate biosynthetic process (GO:0090407),1/39,0.1330256677214299,0.18654771371872397,0,0,7.269371345029239,14.663871680193896,TKT
regulation of nitric-oxide synthase activity (GO:0050999),1/39,0.1330256677214299,0.18654771371872397,0,0,7.269371345029239,14.663871680193896,HIF1A
endothelial cell migration (GO:0043542),1/39,0.1330256677214299,0.18654771371872397,0,0,7.269371345029239,14.663871680193896,MYH9
regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.1330256677214299,0.18654771371872397,0,0,7.269371345029239,14.663871680193896,B2M
response to peptide (GO:1901652),1/39,0.1330256677214299,0.18654771371872397,0,0,7.269371345029239,14.663871680193896,MMP9
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/40,0.13619630195383398,0.1897586251025604,0,0,7.082621082621083,14.12032444596875,TNFAIP3
bone development (GO:0060348),1/40,0.13619630195383398,0.1897586251025604,0,0,7.082621082621083,14.12032444596875,LTF
carboxylic acid metabolic process (GO:0019752),1/40,0.13619630195383398,0.1897586251025604,0,0,7.082621082621083,14.12032444596875,SLC2A3
regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.13619630195383398,0.1897586251025604,0,0,7.082621082621083,14.12032444596875,MMP8
sulfur compound catabolic process (GO:0044273),1/40,0.13619630195383398,0.1897586251025604,0,0,7.082621082621083,14.12032444596875,VCAN
negative regulation of immune response (GO:0050777),2/178,0.1377624460873969,0.19144536056274383,0,0,3.1611715749039693,6.266151688554262,TNFAIP3;MYH9
regulation of translation (GO:0006417),2/178,0.1377624460873969,0.19144536056274383,0,0,3.1611715749039693,6.266151688554262,DDX3X;YBX1
protein stabilization (GO:0050821),2/179,0.139005305783726,0.19192566817267293,0,0,3.1431527015198535,6.2022046177467205,GRN;FLNA
regulation of cell development (GO:0060284),1/41,0.1393554990817365,0.19192566817267293,0,0,6.905208333333333,13.60828094132521,GRN
carbohydrate catabolic process (GO:0016052),1/41,0.1393554990817365,0.19192566817267293,0,0,6.905208333333333,13.60828094132521,PKM
regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.1393554990817365,0.19192566817267293,0,0,6.905208333333333,13.60828094132521,MMP9
regulation of response to DNA damage stimulus (GO:2001020),1/41,0.1393554990817365,0.19192566817267293,0,0,6.905208333333333,13.60828094132521,MCL1
positive regulation of cation transmembrane transport (GO:1904064),1/41,0.1393554990817365,0.19192566817267293,0,0,6.905208333333333,13.60828094132521,FLNA
import into cell (GO:0098657),1/41,0.1393554990817365,0.19192566817267293,0,0,6.905208333333333,13.60828094132521,SLC38A1
negative regulation of protein catabolic process (GO:0042177),1/42,0.14250329979273732,0.1952621550595141,0,0,6.736449864498645,13.125232380756088,FLNA
regulation of ubiquitin-dependent protein catabolic process (GO:2000058),1/42,0.14250329979273732,0.1952621550595141,0,0,6.736449864498645,13.125232380756088,LAPTM5
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.14250329979273732,0.1952621550595141,0,0,6.736449864498645,13.125232380756088,CEACAM8
monocyte chemotaxis (GO:0002548),1/42,0.14250329979273732,0.1952621550595141,0,0,6.736449864498645,13.125232380756088,S100A12
regulation of carbohydrate catabolic process (GO:0043470),1/43,0.14563974461828222,0.19829836277356505,0,0,6.5757275132275135,12.668922941383459,HIF1A
regulation of cytokine production involved in inflammatory response (GO:1900015),1/43,0.14563974461828222,0.19829836277356505,0,0,6.5757275132275135,12.668922941383459,HIF1A
cellular glucose homeostasis (GO:0001678),1/43,0.14563974461828222,0.19829836277356505,0,0,6.5757275132275135,12.668922941383459,HIF1A
negative regulation of type I interferon production (GO:0032480),1/43,0.14563974461828222,0.19829836277356505,0,0,6.5757275132275135,12.668922941383459,TNFAIP3
regulation of purine nucleotide metabolic process (GO:1900542),1/43,0.14563974461828222,0.19829836277356505,0,0,6.5757275132275135,12.668922941383459,HIF1A
regulation of endothelial cell apoptotic process (GO:2000351),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,TNFAIP3
positive regulation of biosynthetic process (GO:0009891),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,MMP8
response to amyloid-beta (GO:1904645),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,MMP9
intracellular steroid hormone receptor signaling pathway (GO:0030518),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,DEFA3
positive regulation of osteoblast differentiation (GO:0045669),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,LTF
positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,FLNA
positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,B2M
mitotic spindle assembly (GO:0090307),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,FLNA
mRNA stabilization (GO:0048255),1/44,0.14876487394350427,0.2002747115464426,0,0,6.422480620155039,12.237319088031208,YBX1
negative regulation of T cell activation (GO:0050868),1/45,0.15187872804092215,0.20294465272961928,0,0,6.276199494949495,11.828583218714314,LAPTM5
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.15187872804092215,0.20294465272961928,0,0,6.276199494949495,11.828583218714314,HIF1A
positive regulation of response to biotic stimulus (GO:0002833),1/45,0.15187872804092215,0.20294465272961928,0,0,6.276199494949495,11.828583218714314,GRN
positive regulation of RNA metabolic process (GO:0051254),1/45,0.15187872804092215,0.20294465272961928,0,0,6.276199494949495,11.828583218714314,SLC38A2
zymogen activation (GO:0031638),1/45,0.15187872804092215,0.20294465272961928,0,0,6.276199494949495,11.828583218714314,VSIR
protein deacetylation (GO:0006476),1/45,0.15187872804092215,0.20294465272961928,0,0,6.276199494949495,11.828583218714314,FLNA
protein transport (GO:0015031),3/369,0.1520675496082188,0.2029451684362474,0,0,2.2905152224824357,4.314026119733446,CD74;LAPTM5;MYH9
positive regulation of protein phosphorylation (GO:0001934),3/371,0.1537976146846648,0.2045525866793566,0,0,2.277833850931677,4.2643731411326264,CD74;DDX3X;MMP9
regulation of B cell proliferation (GO:0030888),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,CD74
regulation of cellular protein localization (GO:1903827),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,LCP1
regulation of fibroblast proliferation (GO:0048145),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,CD74
positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,FLNA
positive regulation of organelle assembly (GO:1902117),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,LCP1
positive regulation of response to stimulus (GO:0048584),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,B2M
positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,MMP9
vesicle organization (GO:0016050),1/46,0.15498134701054317,0.2045525866793566,0,0,6.13641975308642,11.44105094540804,SRGN
negative regulation of macromolecule metabolic process (GO:0010605),2/194,0.15793011227227205,0.20710994427071555,0,0,2.895393192488263,5.343745410234893,MMP8;HIF1A
epithelial to mesenchymal transition (GO:0001837),1/47,0.15807277083614502,0.20710994427071555,0,0,6.002717391304348,11.07321143358293,HIF1A
regulation of T cell activation (GO:0050863),1/47,0.15807277083614502,0.20710994427071555,0,0,6.002717391304348,11.07321143358293,LAPTM5
regulation of wound healing (GO:0061041),1/47,0.15807277083614502,0.20710994427071555,0,0,6.002717391304348,11.07321143358293,TNFAIP3
glycosphingolipid metabolic process (GO:0006687),1/47,0.15807277083614502,0.20710994427071555,0,0,6.002717391304348,11.07321143358293,PSAP
histone deacetylation (GO:0016575),1/47,0.15807277083614502,0.20710994427071555,0,0,6.002717391304348,11.07321143358293,SFPQ
protein localization to membrane (GO:0072657),2/195,0.15920907838989565,0.20834529456369089,0,0,2.880245201780632,5.292557075890418,ITGB2;FLNA
cognition (GO:0050890),1/48,0.1611530393681039,0.2098691939533832,0,0,5.874704491725768,10.72369034010183,HLA-DRA
nucleus organization (GO:0006997),1/48,0.1611530393681039,0.2098691939533832,0,0,5.874704491725768,10.72369034010183,SYNE1
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.1611530393681039,0.2098691939533832,0,0,5.874704491725768,10.72369034010183,HIF1A
positive regulation of endocytosis (GO:0045807),1/48,0.1611530393681039,0.2098691939533832,0,0,5.874704491725768,10.72369034010183,B2M
negative regulation of catabolic process (GO:0009895),1/49,0.16422219226923945,0.21222901552285103,0,0,5.752025462962963,10.391234958525118,FLNA
receptor internalization (GO:0031623),1/49,0.16422219226923945,0.21222901552285103,0,0,5.752025462962963,10.391234958525118,ITGB2
regulation of cellular protein metabolic process (GO:0032268),1/49,0.16422219226923945,0.21222901552285103,0,0,5.752025462962963,10.391234958525118,NFKBIA
regulation of interferon-beta production (GO:0032648),1/49,0.16422219226923945,0.21222901552285103,0,0,5.752025462962963,10.391234958525118,DDX3X
regulation of smooth muscle cell proliferation (GO:0048660),1/49,0.16422219226923945,0.21222901552285103,0,0,5.752025462962963,10.391234958525118,TNFAIP3
response to hydrogen peroxide (GO:0042542),1/49,0.16422219226923945,0.21222901552285103,0,0,5.752025462962963,10.391234958525118,TNFAIP3
endomembrane system organization (GO:0010256),2/199,0.16434447441602393,0.21222901552285103,0,0,2.821191106027025,5.094480380830459,SRGN;SYNE1
regulation of generation of precursor metabolites and energy (GO:0043467),1/50,0.1672802691231711,0.21524593768895492,0,0,5.634353741496598,10.074701240888364,HIF1A
ribosome assembly (GO:0042255),1/50,0.1672802691231711,0.21524593768895492,0,0,5.634353741496598,10.074701240888364,DDX3X
iron ion transport (GO:0006826),1/50,0.1672802691231711,0.21524593768895492,0,0,5.634353741496598,10.074701240888364,LTF
regulation of epithelial cell migration (GO:0010632),1/51,0.17032730933834414,0.21786521633895087,0,0,5.521388888888889,9.773042438478246,HIF1A
negative regulation of protein ubiquitination (GO:0031397),1/51,0.17032730933834414,0.21786521633895087,0,0,5.521388888888889,9.773042438478246,TNFAIP3
positive regulation of actin filament bundle assembly (GO:0032233),1/51,0.17032730933834414,0.21786521633895087,0,0,5.521388888888889,9.773042438478246,PLEK
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.17032730933834414,0.21786521633895087,0,0,5.521388888888889,9.773042438478246,MCL1
mesenchymal cell differentiation (GO:0048762),1/51,0.17032730933834414,0.21786521633895087,0,0,5.521388888888889,9.773042438478246,HIF1A
negative regulation of cellular biosynthetic process (GO:0031327),1/52,0.17336335216475413,0.22017963476584929,0,0,5.412854030501089,9.4852991224055,PLEK
negative regulation of protein metabolic process (GO:0051248),1/52,0.17336335216475413,0.22017963476584929,0,0,5.412854030501089,9.4852991224055,FLNA
negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.17336335216475413,0.22017963476584929,0,0,5.412854030501089,9.4852991224055,DDX3X
glycolipid metabolic process (GO:0006664),1/52,0.17336335216475413,0.22017963476584929,0,0,5.412854030501089,9.4852991224055,PSAP
sprouting angiogenesis (GO:0002040),1/52,0.17336335216475413,0.22017963476584929,0,0,5.412854030501089,9.4852991224055,RNF213
protein homotetramerization (GO:0051289),1/52,0.17336335216475413,0.22017963476584929,0,0,5.412854030501089,9.4852991224055,B2M
regulation of immune effector process (GO:0002697),1/53,0.1763884367943279,0.22323189944476046,0,0,5.308493589743589,9.210590394266864,HLA-DRA
positive regulation of B cell activation (GO:0050871),1/53,0.1763884367943279,0.22323189944476046,0,0,5.308493589743589,9.210590394266864,CD74
IRE1-mediated unfolded protein response (GO:0036498),1/53,0.1763884367943279,0.22323189944476046,0,0,5.308493589743589,9.210590394266864,TLN1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.1794026022045267,0.22624894915020521,0,0,5.2080712788259955,8.948106135360762,RBMX
negative regulation of viral genome replication (GO:0045071),1/54,0.1794026022045267,0.22624894915020521,0,0,5.2080712788259955,8.948106135360762,LTF
regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.1794026022045267,0.22624894915020521,0,0,5.2080712788259955,8.948106135360762,FLNA
pyruvate metabolic process (GO:0006090),1/55,0.18240588726064513,0.22896403330969092,0,0,5.111368312757202,8.697100140634774,PKM
regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.18240588726064513,0.22896403330969092,0,0,5.111368312757202,8.697100140634774,HIF1A
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/55,0.18240588726064513,0.22896403330969092,0,0,5.111368312757202,8.697100140634774,TNFAIP3
glycoprotein metabolic process (GO:0009100),1/55,0.18240588726064513,0.22896403330969092,0,0,5.111368312757202,8.697100140634774,HIF1A
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.18320213204665434,0.22969580467316264,0,0,2.0868542928393303,3.5417364603233286,NAMPT;CYBB;MMP9
negative regulation of multicellular organismal process (GO:0051241),2/214,0.1838520864545959,0.23024267105999974,0,0,2.6195854371512093,4.436592039790376,SRGN;GRN
regulation of ATP metabolic process (GO:1903578),1/56,0.18539833067989295,0.2313719607673751,0,0,5.0181818181818185,8.456884033052678,HIF1A
chemokine-mediated signaling pathway (GO:0070098),1/56,0.18539833067989295,0.2313719607673751,0,0,5.0181818181818185,8.456884033052678,PPBP
glycosaminoglycan catabolic process (GO:0006027),1/56,0.18539833067989295,0.2313719607673751,0,0,5.0181818181818185,8.456884033052678,VCAN
protein modification by small protein conjugation (GO:0032446),3/409,0.18778615726688472,0.23400833778924338,0,0,2.0606263194933145,3.446297424220312,RNF213;HLA-A;HIF1A
regulation of bone mineralization (GO:0030500),1/57,0.18837997108939092,0.23400833778924338,0,0,4.928323412698413,8.22682185145779,SRGN
positive regulation of interferon-gamma production (GO:0032729),1/57,0.18837997108939092,0.23400833778924338,0,0,4.928323412698413,8.22682185145779,HLA-A
protein K48-linked ubiquitination (GO:0070936),1/57,0.18837997108939092,0.23400833778924338,0,0,4.928323412698413,8.22682185145779,TNFAIP3
receptor metabolic process (GO:0043112),1/58,0.1913508469464668,0.23633585110245958,0,0,4.841617933723197,8.006325232895135,ITGB2
cellular iron ion homeostasis (GO:0006879),1/58,0.1913508469464668,0.23633585110245958,0,0,4.841617933723197,8.006325232895135,LCN2
regulation of phagocytosis (GO:0050764),1/58,0.1913508469464668,0.23633585110245958,0,0,4.841617933723197,8.006325232895135,OLFM4
positive regulation of mitochondrion organization (GO:0010822),1/58,0.1913508469464668,0.23633585110245958,0,0,4.841617933723197,8.006325232895135,MMP9
positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.1913508469464668,0.23633585110245958,0,0,4.841617933723197,8.006325232895135,DDX3X
negative regulation of autophagy (GO:0010507),1/59,0.19431099654355077,0.23971700260871043,0,0,4.757902298850575,7.794849109690837,MCL1
cellular response to chemokine (GO:1990869),1/60,0.1972604581015887,0.24252227554270664,0,0,4.6770244821092275,7.591887858510897,PPBP
Notch signaling pathway (GO:0007219),1/60,0.1972604581015887,0.24252227554270664,0,0,4.6770244821092275,7.591887858510897,YBX1
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.1972604581015887,0.24252227554270664,0,0,4.6770244821092275,7.591887858510897,EMB
negative regulation of response to stimulus (GO:0048585),1/61,0.20019926964942997,0.24585474733459076,0,0,4.598842592592592,7.39697185422224,YBX1
regulation of neurogenesis (GO:0050767),1/62,0.2031274691226287,0.24860032300576262,0,0,4.523224043715847,7.2096643705392935,B2M
positive regulation of cysteine-type endopeptidase activity (GO:2001056),1/62,0.2031274691226287,0.24860032300576262,0,0,4.523224043715847,7.2096643705392935,DDX3X
I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.2031274691226287,0.24860032300576262,0,0,4.523224043715847,7.2096643705392935,NFKBIA
negative regulation of endopeptidase activity (GO:0010951),1/63,0.2060450943207102,0.2513960064858117,0,0,4.450044802867383,7.029558795380116,LTF
positive regulation of viral process (GO:0048524),1/63,0.2060450943207102,0.2513960064858117,0,0,4.450044802867383,7.029558795380116,DDX3X
apoptotic process (GO:0006915),2/231,0.2063454686475929,0.2513960064858117,0,0,2.423027246448121,3.824030038709079,NFKBIA;ITGB2
regulation of autophagy (GO:0010506),2/231,0.2063454686475929,0.2513960064858117,0,0,2.423027246448121,3.824030038709079,PSAP;MCL1
regulation of nucleic acid-templated transcription (GO:1903506),3/430,0.20735729035832798,0.25234327877505,0,0,1.95717631314821,3.079248848919394,SFPQ;YBX1;HIF1A
plasma membrane organization (GO:0007009),1/64,0.20895218286419356,0.25371082406396445,0,0,4.379188712522046,6.8562761216168315,MYH9
lipid homeostasis (GO:0055088),1/64,0.20895218286419356,0.25371082406396445,0,0,4.379188712522046,6.8562761216168315,DDX3X
regulation of cellular catabolic process (GO:0031329),1/65,0.21184877234905347,0.2563608177752029,0,0,4.310546875,6.689462678144858,PSAP
chemical homeostasis (GO:0048878),1/65,0.21184877234905347,0.2563608177752029,0,0,4.310546875,6.689462678144858,DDX3X
protein autoubiquitination (GO:0051865),1/65,0.21184877234905347,0.2563608177752029,0,0,4.310546875,6.689462678144858,RNF213
cell-cell junction assembly (GO:0007043),1/66,0.21473490008633264,0.2592707257768837,0,0,4.244017094017094,6.528788087046047,TLN1
positive regulation of cell death (GO:0010942),1/66,0.21473490008633264,0.2592707257768837,0,0,4.244017094017094,6.528788087046047,ITGB2
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),1/67,0.21761060338183918,0.2621550557519472,0,0,4.179503367003367,6.373943403020491,MMP9
vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.21761060338183918,0.2621550557519472,0,0,4.179503367003367,6.373943403020491,CYBB
regulation of translational initiation (GO:0006446),1/68,0.22047591937626412,0.26501402362526394,0,0,4.116915422885572,6.224639434669465,DDX3X
positive regulation of protein localization to nucleus (GO:1900182),1/68,0.22047591937626412,0.26501402362526394,0,0,4.116915422885572,6.224639434669465,FLNA
negative regulation of cellular catabolic process (GO:0031330),1/69,0.2233308850248216,0.267549903416833,0,0,4.056168300653595,6.0806052170528995,MCL1
cellular response to decreased oxygen levels (GO:0036294),1/69,0.2233308850248216,0.267549903416833,0,0,4.056168300653595,6.0806052170528995,HIF1A
positive regulation of MAP kinase activity (GO:0043406),1/69,0.2233308850248216,0.267549903416833,0,0,4.056168300653595,6.0806052170528995,S100A12
carbohydrate homeostasis (GO:0033500),1/70,0.22617553722407738,0.2700566004327399,0,0,3.997181964573269,5.941586619779507,PYGL
negative regulation of viral process (GO:0048525),1/70,0.22617553722407738,0.2700566004327399,0,0,3.997181964573269,5.941586619779507,LTF
wound healing (GO:0042060),1/70,0.22617553722407738,0.2700566004327399,0,0,3.997181964573269,5.941586619779507,MYH9
protein tetramerization (GO:0051262),1/71,0.22900991275740915,0.27163400444904146,0,0,3.9398809523809524,5.807345082506417,B2M
regulation of endopeptidase activity (GO:0052548),1/71,0.22900991275740915,0.27163400444904146,0,0,3.9398809523809524,5.807345082506417,VSIR
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.22900991275740915,0.27163400444904146,0,0,3.9398809523809524,5.807345082506417,DDX3X
regulation of glycolytic process (GO:0006110),1/71,0.22900991275740915,0.27163400444904146,0,0,3.9398809523809524,5.807345082506417,HIF1A
nucleic acid metabolic process (GO:0090304),1/71,0.22900991275740915,0.27163400444904146,0,0,3.9398809523809524,5.807345082506417,RBMX
response to metal ion (GO:0010038),1/71,0.22900991275740915,0.27163400444904146,0,0,3.9398809523809524,5.807345082506417,HIF1A
negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.23183404813143674,0.2743794174039092,0,0,3.884194053208138,5.677656463396951,B2M
cell junction organization (GO:0034330),1/72,0.23183404813143674,0.2743794174039092,0,0,3.884194053208138,5.677656463396951,FLNA
positive regulation of JNK cascade (GO:0046330),1/73,0.23464797994946024,0.27710073947979025,0,0,3.830054012345679,5.552309978509986,MMP8
insulin receptor signaling pathway (GO:0008286),1/73,0.23464797994946024,0.27710073947979025,0,0,3.830054012345679,5.552309978509986,NAMPT
proteolysis involved in cellular protein catabolic process (GO:0051603),1/74,0.23745174446847134,0.27949238119403674,0,0,3.7773972602739727,5.431107245351442,TNFAIP3
negative regulation of protein binding (GO:0032091),1/74,0.23745174446847134,0.27949238119403674,0,0,3.7773972602739727,5.431107245351442,B2M
mitotic nuclear division (GO:0140014),1/74,0.23745174446847134,0.27949238119403674,0,0,3.7773972602739727,5.431107245351442,FLNA
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.2402453780074235,0.28216387362485834,0,0,3.7261636636636637,5.313861393498236,HIF1A
positive regulation of T cell activation (GO:0050870),1/75,0.2402453780074235,0.28216387362485834,0,0,3.7261636636636637,5.313861393498236,HLA-A
actomyosin structure organization (GO:0031032),1/76,0.24302891658145068,0.2838851878071826,0,0,3.676296296296296,5.200396261462457,MYH9
phospholipid metabolic process (GO:0006644),1/76,0.24302891658145068,0.2838851878071826,0,0,3.676296296296296,5.200396261462457,PLBD1
regulation of RNA splicing (GO:0043484),1/76,0.24302891658145068,0.2838851878071826,0,0,3.676296296296296,5.200396261462457,SLC38A2
RNA transport (GO:0050658),1/76,0.24302891658145068,0.2838851878071826,0,0,3.676296296296296,5.200396261462457,YBX1
water-soluble vitamin metabolic process (GO:0006767),1/76,0.24302891658145068,0.2838851878071826,0,0,3.676296296296296,5.200396261462457,SLC2A3
regulation of cellular macromolecule biosynthetic process (GO:2000112),3/468,0.2438547995258425,0.2845412991217035,0,0,1.7937327188940093,2.5312838902595924,SFPQ;YBX1;HIF1A
cellular response to UV (GO:0034644),1/77,0.24580239617986321,0.28526851366994904,0,0,3.6277412280701755,5.090545649743084,MMP9
phosphatidylcholine metabolic process (GO:0046470),1/77,0.24580239617986321,0.28526851366994904,0,0,3.6277412280701755,5.090545649743084,PLBD1
positive regulation of endothelial cell proliferation (GO:0001938),1/77,0.24580239617986321,0.28526851366994904,0,0,3.6277412280701755,5.090545649743084,HIF1A
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.24580239617986321,0.28526851366994904,0,0,3.6277412280701755,5.090545649743084,LAPTM5
positive regulation of type I interferon production (GO:0032481),1/77,0.24580239617986321,0.28526851366994904,0,0,3.6277412280701755,5.090545649743084,DDX3X
recombinational repair (GO:0000725),1/79,0.2513193218281669,0.29073137444568825,0,0,3.534366096866097,4.8810689680161286,SFPQ
regulation of ion transport (GO:0043269),1/79,0.2513193218281669,0.29073137444568825,0,0,3.534366096866097,4.8810689680161286,B2M
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),1/79,0.2513193218281669,0.29073137444568825,0,0,3.534366096866097,4.8810689680161286,LAPTM5
negative regulation of cellular component organization (GO:0051129),1/80,0.2540628391818678,0.2929611111336955,0,0,3.4894514767932487,4.781154446243804,DDX3X
glycerophospholipid metabolic process (GO:0006650),1/80,0.2540628391818678,0.2929611111336955,0,0,3.4894514767932487,4.781154446243804,PLEK
response to interferon-gamma (GO:0034341),1/80,0.2540628391818678,0.2929611111336955,0,0,3.4894514767932487,4.781154446243804,CD74
positive regulation of cellular amide metabolic process (GO:0034250),1/81,0.2567964401726413,0.29579654124698895,0,0,3.445659722222222,4.684276430596063,DDX3X
cell-cell junction organization (GO:0045216),1/82,0.2595201601845837,0.2973438431051028,0,0,3.402949245541838,4.590309327715687,TLN1
regulation of G protein-coupled receptor signaling pathway (GO:0008277),1/82,0.2595201601845837,0.2973438431051028,0,0,3.402949245541838,4.590309327715687,PLEK
ephrin receptor signaling pathway (GO:0048013),1/82,0.2595201601845837,0.2973438431051028,0,0,3.402949245541838,4.590309327715687,MMP9
positive regulation of cytoskeleton organization (GO:0051495),1/82,0.2595201601845837,0.2973438431051028,0,0,3.402949245541838,4.590309327715687,PLEK
positive regulation of protein ubiquitination (GO:0031398),1/82,0.2595201601845837,0.2973438431051028,0,0,3.402949245541838,4.590309327715687,LAPTM5
regulation of defense response (GO:0031347),1/83,0.26223403450441707,0.29918014317929786,0,0,3.361280487804878,4.49913414177752,GRN
regulation of interleukin-1 beta production (GO:0032651),1/83,0.26223403450441707,0.29918014317929786,0,0,3.361280487804878,4.49913414177752,TNFAIP3
regulation of osteoblast differentiation (GO:0045667),1/83,0.26223403450441707,0.29918014317929786,0,0,3.361280487804878,4.49913414177752,LTF
epidermis development (GO:0008544),1/83,0.26223403450441707,0.29918014317929786,0,0,3.361280487804878,4.49913414177752,YBX1
response to insulin (GO:0032868),1/84,0.2649380981124827,0.30162614341135713,0,0,3.320615796519411,4.410638057386621,PKM
spindle assembly (GO:0051225),1/84,0.2649380981124827,0.30162614341135713,0,0,3.320615796519411,4.410638057386621,FLNA
negative regulation of defense response (GO:0031348),1/85,0.2676323860406366,0.3037303264128194,0,0,3.280919312169312,4.324714046464854,TNFAIP3
regulation of cell cycle G2/M phase transition (GO:1902749),1/85,0.2676323860406366,0.3037303264128194,0,0,3.280919312169312,4.324714046464854,TUBA1A
positive regulation of protein catabolic process (GO:0045732),1/85,0.2676323860406366,0.3037303264128194,0,0,3.280919312169312,4.324714046464854,TNFAIP3
regulation of neuron death (GO:1901214),1/86,0.27031693312159105,0.3064540389178459,0,0,3.242156862745098,4.241260511650994,ITGB2
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.2729917741243003,0.3091610312637975,0,0,3.204295865633075,4.1601809509671455,HIF1A
negative regulation of binding (GO:0051100),1/88,0.2756569436541569,0.31152416402468724,0,0,3.1673052362707534,4.081383649422967,NFKBIA
positive regulation of neuron projection development (GO:0010976),1/88,0.2756569436541569,0.31152416402468724,0,0,3.1673052362707534,4.081383649422967,S100A9
regulation of cation channel activity (GO:2001257),1/89,0.27831247612889637,0.3132105922579116,0,0,3.131155303030303,4.004781391662347,MMP9
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),1/89,0.27831247612889637,0.3132105922579116,0,0,3.131155303030303,4.004781391662347,DDX3X
regulation of endothelial cell migration (GO:0010594),1/89,0.27831247612889637,0.3132105922579116,0,0,3.131155303030303,4.004781391662347,GRN
regulation of type I interferon production (GO:0032479),1/89,0.27831247612889637,0.3132105922579116,0,0,3.131155303030303,4.004781391662347,TNFAIP3
"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.28095840598002714,0.3158582497291119,0,0,3.0958177278402,3.930291192345841,RBMX
positive regulation of supramolecular fiber organization (GO:1902905),1/91,0.2835947674102115,0.31848963972971617,0,0,3.0612654320987653,3.857834050222409,PLEK
regulation of endothelial cell proliferation (GO:0001936),1/92,0.2862215945871041,0.32010452478744666,0,0,3.0274725274725274,3.78733471438743,HIF1A
regulation of lipid metabolic process (GO:0019216),1/92,0.2862215945871041,0.32010452478744666,0,0,3.0274725274725274,3.78733471438743,PSAP
positive regulation of cellular component biogenesis (GO:0044089),1/92,0.2862215945871041,0.32010452478744666,0,0,3.0274725274725274,3.78733471438743,PLEK
Wnt signaling pathway (GO:0016055),1/92,0.2862215945871041,0.32010452478744666,0,0,3.0274725274725274,3.78733471438743,DDX3X
regulation of kinase activity (GO:0043549),1/94,0.2914467819279733,0.3249360084228025,0,0,2.9620669056152926,3.6519259376872046,CD74
hemopoiesis (GO:0030097),1/94,0.2914467819279733,0.3249360084228025,0,0,2.9620669056152926,3.6519259376872046,PLEK
interleukin-1-mediated signaling pathway (GO:0070498),1/94,0.2914467819279733,0.3249360084228025,0,0,2.9620669056152926,3.6519259376872046,NFKBIA
ciliary basal body-plasma membrane docking (GO:0097711),1/95,0.2940452098260922,0.3271556725027906,0,0,2.93040780141844,3.58688288104775,TUBA1A
mRNA metabolic process (GO:0016071),1/95,0.2940452098260922,0.3271556725027906,0,0,2.93040780141844,3.58688288104775,SFPQ
cellular transition metal ion homeostasis (GO:0046916),1/96,0.2966342386868027,0.3293557474903985,0,0,2.8994152046783626,3.5235300385346275,LCN2
regulation of vesicle-mediated transport (GO:0060627),1/96,0.2966342386868027,0.3293557474903985,0,0,2.8994152046783626,3.5235300385346275,OLFM4
protein maturation (GO:0051604),1/97,0.2992139021231464,0.3305162795760294,0,0,2.869068287037037,3.4618079532187815,SRGN
regulation of MAP kinase activity (GO:0043405),1/97,0.2992139021231464,0.3305162795760294,0,0,2.869068287037037,3.4618079532187815,S100A12
double-strand break repair via homologous recombination (GO:0000724),1/97,0.2992139021231464,0.3305162795760294,0,0,2.869068287037037,3.4618079532187815,SFPQ
positive regulation of cold-induced thermogenesis (GO:0120162),1/97,0.2992139021231464,0.3305162795760294,0,0,2.869068287037037,3.4618079532187815,LCN2
glycosaminoglycan biosynthetic process (GO:0006024),1/97,0.2992139021231464,0.3305162795760294,0,0,2.869068287037037,3.4618079532187815,VCAN
protein ubiquitination (GO:0016567),3/525,0.30029261028554105,0.33136797262041773,0,0,1.5931855500821017,1.9165988902878826,RNF213;HLA-A;HIF1A
negative regulation of neuron death (GO:1901215),1/98,0.301784233455671,0.33199348256563604,0,0,2.839347079037801,3.4016598236456796,GRN
regulation of neuron apoptotic process (GO:0043523),1/98,0.301784233455671,0.33199348256563604,0,0,2.839347079037801,3.4016598236456796,GRN
RNA splicing (GO:0008380),1/98,0.301784233455671,0.33199348256563604,0,0,2.839347079037801,3.4016598236456796,SFPQ
positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.30434526608940626,0.3344692363043781,0,0,2.810232426303855,3.343031356689387,MMP8
cell-matrix adhesion (GO:0007160),1/100,0.30689703311188365,0.33692977029714444,0,0,2.781705948372615,3.2858706369655613,ITGB2
positive regulation of protein localization to membrane (GO:1905477),1/101,0.30943956761110974,0.3393751673290888,0,0,2.75375,3.230127997864633,ITGB2
regulation of cell death (GO:0010941),1/102,0.3119729025515113,0.34180550971310036,0,0,2.7263476347634765,3.1757559046009254,OLFM4
protein polyubiquitination (GO:0000209),2/314,0.31831317549825683,0.3480439492503783,0,0,1.7709461899602745,2.0272367295710723,RNF213;TNFAIP3
cilium assembly (GO:0060271),2/314,0.31831317549825683,0.3480439492503783,0,0,1.7709461899602745,2.0272367295710723,TUBA1A;FLNA
cellular protein modification process (GO:0006464),5/1025,0.31925994109488465,0.34830053280243,0,0,1.3629613610149942,1.55616065097484,VCAN;APLP2;STK17B;F13A1;HIF1A
regulation of JNK cascade (GO:0046328),1/105,0.3195180375197779,0.34830053280243,0,0,2.6473023504273505,3.0204172504491282,MMP8
positive regulation of cellular metabolic process (GO:0031325),1/105,0.3195180375197779,0.34830053280243,0,0,2.6473023504273505,3.0204172504491282,NFKBIA
cellular response to peptide hormone stimulus (GO:0071375),1/106,0.32201490119774046,0.35066738987863144,0,0,2.621957671957672,2.9710908892199424,PKM
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),3/547,0.32234273403199526,0.3506698227802615,0,0,1.5270220588235295,1.7288026133384211,SFPQ;DDX3X;YBX1
regulation of Wnt signaling pathway (GO:0030111),1/111,0.33436431399957883,0.36338079331740303,0,0,2.5021464646464646,2.741161803729472,TNFAIP3
protein-containing complex subunit organization (GO:0043933),1/112,0.3368074396256327,0.3656669480612968,0,0,2.4794794794794797,2.6982784378310085,CD74
positive regulation of metabolic process (GO:0009893),1/113,0.33924172042330947,0.367568745368113,0,0,2.457217261904762,2.6563560119679144,LCN2
sulfur compound biosynthetic process (GO:0044272),1/113,0.33924172042330947,0.367568745368113,0,0,2.457217261904762,2.6563560119679144,VCAN
negative regulation of cell motility (GO:2000146),1/114,0.341667188006915,0.36945337498338093,0,0,2.435349065880039,2.615365563933378,CD74
positive regulation of kinase activity (GO:0033674),1/114,0.341667188006915,0.36945337498338093,0,0,2.435349065880039,2.615365563933378,CD74
cytosolic transport (GO:0016482),1/116,0.3464918093592559,0.3731716786799186,0,0,2.3927536231884057,2.536070230713175,LAPTM5
regulation of protein-containing complex assembly (GO:0043254),1/116,0.3464918093592559,0.3731716786799186,0,0,2.3927536231884057,2.536070230713175,DDX3X
sphingolipid metabolic process (GO:0006665),1/116,0.3464918093592559,0.3731716786799186,0,0,2.3927536231884057,2.536070230713175,PSAP
tumor necrosis factor-mediated signaling pathway (GO:0033209),1/116,0.3464918093592559,0.3731716786799186,0,0,2.3927536231884057,2.536070230713175,NFKBIA
intracellular protein transport (GO:0006886),2/336,0.3477166923603506,0.3741167609111864,0,0,1.6524415956818757,1.745585156424948,CD74;LAPTM5
positive regulation of cell projection organization (GO:0031346),1/117,0.3488910257171415,0.37500562345046046,0,0,2.372006704980843,2.4977127486810127,S100A9
regulation of protein binding (GO:0043393),1/118,0.3512815540389537,0.37719863778659335,0,0,2.351614434947768,2.4601819566297687,B2M
innate immune response activating cell surface receptor signaling pathway (GO:0002220),1/119,0.3536634254179616,0.37937799718639903,0,0,2.3315677966101696,2.4234539363397634,FCN1
cytoskeleton organization (GO:0007010),1/120,0.35603667068127076,0.38154377544649615,0,0,2.3118580765639587,2.387505646738297,TNFAIP3
regulation of anatomical structure morphogenesis (GO:0022603),1/123,0.3631049577034895,0.388731649549362,0,0,2.2546675774134792,2.2841210819660067,TNFAIP3
defense response to symbiont (GO:0140546),1/124,0.36544400573697,0.39084726333536907,0,0,2.236224028906956,2.2510774998703584,FLNA
regulation of phosphorylation (GO:0042325),1/125,0.3677745806719697,0.39294962637272957,0,0,2.2180779569892475,2.2187102889200414,HIF1A
negative regulation of cell growth (GO:0030308),1/126,0.3700967127128955,0.394647682764147,0,0,2.200222222222222,2.187000914806498,DDX3X
negative regulation of growth (GO:0045926),1/126,0.3700967127128955,0.394647682764147,0,0,2.200222222222222,2.187000914806498,DDX3X
ubiquitin-dependent protein catabolic process (GO:0006511),2/354,0.3714764222820734,0.3957271086031583,0,0,1.5665012804097311,1.5512590398346784,RNF213;TNFAIP3
plasma membrane bounded cell projection organization (GO:0120036),1/128,0.37471576891581854,0.39878348134618236,0,0,2.1653543307086616,2.1254847223511613,PLEK
regulation of primary metabolic process (GO:0080090),1/130,0.37930141429119896,0.40167907885115167,0,0,2.131567614125754,2.0663930193377014,PSAP
regulation of response to external stimulus (GO:0032101),1/130,0.37930141429119896,0.40167907885115167,0,0,2.131567614125754,2.0663930193377014,GRN
positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.37930141429119896,0.40167907885115167,0,0,2.131567614125754,2.0663930193377014,DDX3X
G2/M transition of mitotic cell cycle (GO:0000086),1/130,0.37930141429119896,0.40167907885115167,0,0,2.131567614125754,2.0663930193377014,TUBA1A
Golgi organization (GO:0007030),1/130,0.37930141429119896,0.40167907885115167,0,0,2.131567614125754,2.0663930193377014,SYNE1
cell cycle G2/M phase transition (GO:0044839),1/131,0.3815817824645011,0.40330086331135195,0,0,2.1150641025641024,2.037716378427825,TUBA1A
cellular response to hypoxia (GO:0071456),1/131,0.3815817824645011,0.40330086331135195,0,0,2.1150641025641024,2.037716378427825,HIF1A
regulation of cell motility (GO:2000145),1/133,0.38611775801475434,0.4072956174161512,0,0,2.082807239057239,1.982026202461866,FLNA
defense response to virus (GO:0051607),1/133,0.38611775801475434,0.4072956174161512,0,0,2.082807239057239,1.982026202461866,FLNA
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),1/134,0.3883734243245031,0.4092741467685811,0,0,2.067042606516291,1.9549840273622543,CD74
protein localization to plasma membrane (GO:0072659),1/136,0.3928602606176439,0.4127907323758073,0,0,2.0362139917695474,1.9024373822165888,FLNA
negative regulation of inflammatory response to antigenic stimulus (GO:0002862),1/136,0.3928602606176439,0.4127907323758073,0,0,2.0362139917695474,1.9024373822165888,MYH9
organic substance transport (GO:0071702),1/136,0.3928602606176439,0.4127907323758073,0,0,2.0362139917695474,1.9024373822165888,MYH9
regulation of inflammatory response to antigenic stimulus (GO:0002861),1/137,0.395091488951388,0.4147305395717787,0,0,2.021139705882353,1.876906979173357,MYH9
protein localization to cell periphery (GO:1990778),1/140,0.4017367625718065,0.42129551440100843,0,0,1.9772182254196642,1.8031404219550526,FLNA
negative regulation of cell population proliferation (GO:0008285),2/379,0.4039075303771577,0.423159932116925,0,0,1.4607539134008294,1.3242746708928346,TNFAIP3;B2M
receptor-mediated endocytosis (GO:0006898),1/143,0.4083100229591629,0.4273565546423892,0,0,1.9351525821596245,1.7333713834165307,ITGB2
negative regulation of cell migration (GO:0030336),1/144,0.41048524010113935,0.42921611998924963,0,0,1.9215229215229215,1.7109534213850381,CD74
regulation of mRNA stability (GO:0043488),1/146,0.4148120398489358,0.4333196575337573,0,0,1.8948275862068966,1.667315216096072,YBX1
positive regulation of transferase activity (GO:0051347),1/148,0.41910751443185734,0.4373825513983628,0,0,1.8688586545729402,1.6252114296088644,CD74
regulation of G2/M transition of mitotic cell cycle (GO:0010389),1/149,0.4212435747546531,0.4387614410162103,0,0,1.8561373873873874,1.6047125346934792,TUBA1A
positive regulation of hydrolase activity (GO:0051345),1/149,0.4212435747546531,0.4387614410162103,0,0,1.8561373873873874,1.6047125346934792,PSAP
mitotic spindle organization (GO:0007052),1/157,0.4380554613204421,0.4558316249682281,0,0,1.760238603988604,1.4529181106397113,FLNA
protein autophosphorylation (GO:0046777),1/159,0.4421826034638887,0.4596821080411276,0,0,1.73778129395218,1.4180857569309369,STK17B
cellular protein metabolic process (GO:0044267),2/417,0.451660443459675,0.4690822542006461,0,0,1.324418801968437,1.0526806613926272,VCAN;APLP2
double-strand break repair (GO:0006302),1/164,0.452370116678941,0.46936668175647345,0,0,1.6840490797546013,1.335879665682592,SFPQ
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.45438548760257985,0.4705511251422871,0,0,1.6736957994579946,1.3202268949644533,PSAP
regulation of neuron projection development (GO:0010975),1/165,0.45438548760257985,0.4705511251422871,0,0,1.6736957994579946,1.3202268949644533,S100A9
organelle organization (GO:0006996),2/420,0.4553416567092919,0.47108834224390717,0,0,1.3147112339106408,1.034292856671376,TNFAIP3;SYNE1
organelle assembly (GO:0070925),2/425,0.4614463496440732,0.4769459871081255,0,0,1.2988379449272467,1.0045076079263098,DDX3X;FLNA
positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.46828970487693317,0.48355514108576897,0,0,1.6046133853151396,1.217369063797829,CD74
RNA processing (GO:0006396),1/179,0.48184432327148907,0.497075034639266,0,0,1.5409644194756553,1.125110820353292,SFPQ
nervous system development (GO:0007399),2/447,0.4878371907762376,0.502775745900486,0,0,1.2332331065041937,0.8851821100778281,VCAN;ITM2B
regulation of mitotic cell cycle phase transition (GO:1901990),1/188,0.4987719236575012,0.5135538831540428,0,0,1.4661319073083778,1.0198506713118856,TUBA1A
negative regulation of cell differentiation (GO:0045596),1/191,0.5042923269515328,0.5182469810370237,0,0,1.4427631578947369,0.9877144535641057,NFKBIA
negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.5042923269515328,0.5182469810370237,0,0,1.4427631578947369,0.9877144535641057,RNF213
cellular response to tumor necrosis factor (GO:0071356),1/194,0.50975275351866145,0.5228606814662842,0,0,1.4201208981001727,0.9569193090325593,NFKBIA
regulation of programmed cell death (GO:0043067),1/194,0.50975275351866145,0.5228606814662842,0,0,1.4201208981001727,0.9569193090325593,OLFM4
modification-dependent protein catabolic process (GO:0019941),1/201,0.5222641034285848,0.5351840527046486,0,0,1.3699305555555557,0.8898820572278457,RNF213
axon guidance (GO:0007411),1/203,0.5257805657187454,0.5382753510257497,0,0,1.3562293729372936,0.8718809790373695,EMB
mitotic cell cycle phase transition (GO:0044772),1/209,0.536177492654316,0.5483980622874629,0,0,1.3167067307692308,0.8206901773474864,TUBA1A
phosphate-containing compound metabolic process (GO:0006796),1/212,0.5412913196519876,0.5531031795684921,0,0,1.297788309636651,0.7965794294743186,PLBD1
"transcription, DNA-templated (GO:0006351)",1/221,0.5563014714015769,0.5679020708052117,0,0,1.244128787878788,0.7296130036525972,RBMX
positive regulation of nucleic acid-templated transcription (GO:1903508),2/511,0.5599489736039986,0.5710843225108962,0,0,1.0746285176678934,0.6231874131391432,CD74;HIF1A
cilium organization (GO:0044782),1/228,0.5676401600218424,0.5783807496154438,0,0,1.205335291238375,0.6825423009996844,FLNA
regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.5833441207463798,0.593820054861863,0,0,1.153891233005157,0.6219219984394793,CD74
axonogenesis (GO:0007409),1/240,0.5864167224810847,0.596384145526089,0,0,1.1441190144119013,0.6106444766195653,EMB
regulation of canonical Wnt signaling pathway (GO:0060828),1/253,0.6058509448038474,0.6155674222205129,0,0,1.0843805114638447,0.5434061594950922,DDX3X
positive regulation of cell differentiation (GO:0045597),1/258,0.61308336301661,0.6223287294711489,0,0,1.063013402507566,0.5200839423633136,LTF
negative regulation of cellular process (GO:0048523),2/566,0.6160441257878206,0.6247453140051628,0,0,0.9670862051743082,0.4684920355776026,DDX3X;MYH9
protein-containing complex assembly (GO:0065003),1/267,0.6257733534039627,0.6340149591872698,0,0,1.026576858813701,0.4812253838435193,CD74
central nervous system development (GO:0007417),1/268,0.6271577576981391,0.6348203994745262,0,0,1.0226799833541407,0.4771386715095065,VCAN
plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.6407269438811968,0.6479464024038017,0,0,0.9852587244283996,0.4385897906125475,FLNA
transcription by RNA polymerase II (GO:0006366),1/320,0.6925933152519633,0.699740150587584,0,0,0.8537095088819227,0.3135780021571331,RBMX
regulation of transcription by RNA polymerase II (GO:0006357),7/2206,0.7078815728092357,0.7145158893304094,0,0,0.8550443038846859,0.2953993973094858,NFKBIA;SFPQ;DDX3X;NAMPT;YBX1;HIF1A;RBMX
positive regulation of multicellular organismal process (GO:0051240),1/345,0.7198825272650539,0.7259489530566133,0,0,0.790657299741602,0.25986315000912846,LCN2
cellular response to DNA damage stimulus (GO:0006974),1/350,0.7250464018030376,0.7304723804881865,0,0,0.7791308500477555,0.25050585771152223,MCL1
phosphorylation (GO:0016310),1/400,0.7717882179524793,0.7768372997521685,0,0,0.6797549429128377,0.17608718421871544,STK17B
regulation of intracellular signal transduction (GO:1902531),1/437,0.8012426982719464,0.8057314528841142,0,0,0.6208906727828746,0.13758402331453284,NFKBIA
negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.8203378365934644,0.8241640391895161,0,0,0.583873290136789,0.11562969869336524,SFPQ
protein phosphorylation (GO:0006468),1/496,0.840636784431571,0.8437705655478117,0,0,0.5452300785634119,0.09464954133708608,STK17B
"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.8667324013599034,0.8691534415871657,0,0,0.5651966768900932,0.08083725403057895,SFPQ;FLNA
negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.9215219164431694,0.9232363758225985,0,0,0.3913291036277859,0.03198282623405706,SFPQ
regulation of cell population proliferation (GO:0042127),1/764,0.9420666399204468,0.9429421665374732,0,0,0.3488422892092617,0.02081865103462058,NAMPT
"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.970231317616251,0.970231317616251,0,0,0.4577380952380952,0.013833195016486569,CD74;SFPQ;YBX1;HIF1A
